Gideon Koren

Q: What Schools Are Affiliated With Gideon Koren

Gideon Koren is affiliated with the following schools: University of Western Ontario, Canadian College of Naturopathic Medicine, University of British Columbia, Ariel University, Tel Aviv University, Ben-Gurion University of the Negev, University of Toronto

Gideon Koren's AcademicInfluence.com Rankings

Gideon Koren

Medical

#101

World Rank

#165

Historical Rank

Pharmacology

#18

World Rank

#24

Historical Rank

medical Degrees

Gideon Koren

Philosophy

#1699

World Rank

#3035

Historical Rank

Logic

#305

World Rank

#614

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Gideon Koren Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gideon Koren, FACMT, FRCP is an Israeli-Canadian pediatrician, clinical pharmacologist, toxicologist, and a composer of Israeli folk music. He was a doctor at the Hospital for Sick Children and a professor at the University of Toronto. In 1985, Koren founded the Motherisk Program in Toronto, which was later shut down amid controversy. Furthermore, multiple scientific papers authored by Koren have been subject to concerns regarding academic and research misconduct, leading to the retraction of six research articles and editorial expression of concerns on multiple others. Koren currently has relinquished his licence to practice medicine due to an ongoing investigation into whether he committed “professional misconduct or was incompetent” while he was in charge of the Hospital for Sick Children’s Motherisk laboratory.

(See a Problem?)

Gideon Koren's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevalence of Depression During Pregnancy: Systematic Review (2004) (1583)
Effect of neonatal circumcision on pain response during subsequent routine vaccination (1997) (1135)
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. (2000) (846)
Survival in Medically Treated Patients with Homozygous β-Thalassemia (1994) (781)
Hair cortisol as a biological marker of chronic stress: Current status, future directions and unanswered questions (2012) (774)
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. (2013) (645)
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother (2006) (627)
Neurodevelopment of children exposed in utero to antidepressant drugs (1997) (532)
Perinatal Risks of Untreated Depression during Pregnancy (2004) (514)
Fetal alcohol spectrum disorder. (2003) (506)
Measurement of cortisol in human hair as a biomarker of systemic exposure. (2007) (488)
Effect of neonatal circumcision on pain responses during vaccination in boys (1995) (469)
Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis (2000) (462)
Survival in medically treated patients with homozygous beta-thalassemia. (1994) (434)
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. (2002) (425)
Colchicine poisoning: the dark side of an ancient drug (2010) (413)
Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. (2001) (399)
Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. (1985) (397)
Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. (1996) (387)
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. (2009) (383)
Socio-economic disparities in preterm birth: causal pathways and mechanisms. (2001) (364)
Pregnancy outcome following non-obstetric surgical intervention. (2005) (355)
Drugs in pregnancy. (1998) (355)
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. (1998) (349)
More Codeine Fatalities After Tonsillectomy in North American Children (2012) (340)
Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester (1992) (321)
Elevated content of cortisol in hair of patients with severe chronic pain: A novel biomarker for stress (2008) (312)
Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study (2009) (312)
Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology (2009) (311)
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. (2005) (307)
Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies (1998) (304)
Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance (1997) (304)
Iron-chelation therapy with oral deferiprone in patients with thalassemia major. (1995) (303)
An assessment of cortisol analysis in hair and its clinical applications. (2010) (297)
Variables associated with medication errors in pediatric emergency medicine. (2002) (289)
Fetal outcome after in utero exposure to cancer chemotherapy. (1992) (285)
Maternal Hyperthermia and the Risk for Neural Tube Defects in Offspring: Systematic Review and Meta-Analysis (2005) (280)
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction (2008) (279)
Safety of metronidazole in pregnancy: a meta-analysis. (1995) (277)
Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. (2002) (268)
Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association (2015) (250)
Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. (2006) (249)
Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. (1997) (237)
The relationship between stress and hair cortisol in healthy pregnant women. (2007) (234)
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. (2013) (231)
Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. (2001) (229)
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. (2013) (229)
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. (2007) (228)
Perinatal outcome following third trimester exposure to paroxetine. (2002) (223)
Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. (2005) (223)
DEET-based insect repellents: safety implications for children and pregnant and lactating women. (2003) (223)
A novel method using hair for determining hormonal levels in wildlife (2002) (210)
A systematic review of lidocaine-prilocaine cream (EMLA) in the treatment of acute pain in neonates. (1998) (209)
Hair analysis provides a historical record of cortisol levels in Cushing's syndrome. (2009) (209)
Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling. (2001) (206)
Pregnancy Outcome After First-Trimester Exposure to Metformin: A Meta-Analysis (2006) (204)
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study (2004) (202)
Pregnancy Outcome Following Gestational Exposure to Fluoroquinolones: a Multicenter Prospective Controlled Study (1998) (202)
Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. (2002) (197)
FETAL GENITAL EFFECTS OF FIRST‐TRIMESTER SEX HORMONE EXPOSURE: A META‐ANALYSIS (1995) (194)
A revised measure of acute pain in infants. (1995) (193)
The safety of mesalamine in human pregnancy: a prospective controlled cohort study. (1998) (192)
Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. (1993) (191)
Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. (2013) (186)
Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children (2002) (185)
Pregnancy outcome of women exposed to azathioprine during pregnancy. (2007) (182)
The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. (1996) (181)
Antioxidants and fetal protection against ethanol teratogenicity. I. Review of the experimental data and implications to humans. (2003) (180)
Codeine, ultrarapid-metabolism genotype, and postoperative death. (2009) (178)
The Safety of Proton Pump Inhibitors (PPIs) in Pregnancy: A Meta-Analysis (2009) (177)
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. (2008) (177)
Antidepressant Use during Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis (2005) (177)
Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. (2011) (176)
Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis. (1997) (176)
Empirical examination of the ability of children to consent to clinical research. (1998) (176)
Nonsteroidal Antiinflammatory Drugs During Third Trimester and the Risk of Premature Closure of the Ductus Arteriosus: A Meta-Analysis (2006) (176)
Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. (1985) (175)
Hair Cortisol as a Potential Biologic Marker of Chronic Stress in Hospitalized Neonates (2007) (172)
Use of antidepressants by pregnant women: Evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making (2005) (172)
Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. (2003) (171)
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review (2016) (170)
The safety of metoclopramide use in the first trimester of pregnancy. (2009) (170)
Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. (1999) (170)
The burden of prenatal exposure to alcohol: revised measurement of cost. (2009) (169)
BIAS AGAINST THE NULL HYPOTHESIS: THE REPRODUCTIVE HAZARDS OF COCAINE (1989) (166)
Use of lidocaine-prilocaine cream for vaccination pain in infants. (1994) (166)
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women (2009) (166)
Errors by paediatric residents in calculating drug doses (1998) (164)
Social cognitive and emotion processing abilities of children with fetal alcohol spectrum disorders: a comparison with attention deficit hyperactivity disorder. (2009) (164)
Maternal and fetal outcome after breast cancer in pregnancy. (1992) (164)
Topical skin anesthesia for venous, subcutaneous drug reservoir and lumbar punctures in children. (1989) (163)
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. (2007) (162)
Herbal medicine use in pregnancy: results of a multinational study (2013) (162)
Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). (2002) (161)
Immunological and autoimmune considerations of Autism Spectrum Disorders. (2013) (161)
Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. (1991) (160)
Depression during Pregnancy (2004) (160)
The Human Placental Perfusion Model: A Systematic Review and Development of a Model to Predict In Vivo Transfer of Therapeutic Drugs (2011) (160)
Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients (1990) (160)
Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry (2015) (160)
Kawasaki disease: review of risk factors for coronary aneurysms. (1986) (160)
Fetal effects of cocaine: an updated meta-analysis. (2001) (159)
Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children (2011) (159)
A 2013 updated systematic review & meta‐analysis of 36 randomized controlled trials; no apparent effects of non steroidal anti‐inflammatory agents on the risk of bleeding after tonsillectomy (2013) (159)
Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. (1986) (159)
Cancer in pregnancy: gaps, challenges and solutions. (2008) (156)
Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. (2015) (156)
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. (2013) (154)
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. (2004) (154)
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. (2012) (154)
Malformation Rates in Children of Women with Untreated Epilepsy (2004) (151)
Bias against negative studies in newspaper reports of medical research. (1991) (149)
Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis (2014) (148)
Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study (2014) (148)
Use of misoprostol during pregnancy and Möbius' syndrome in infants. (1998) (147)
The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study) (2016) (146)
Transport of glyburide by placental ABC transporters: implications in fetal drug exposure. (2006) (146)
Identifying the behavioural phenotype in fetal alcohol spectrum disorder: sensitivity, specificity and screening potential (2006) (146)
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial (2005) (146)
Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases (2001) (145)
Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes. (2006) (145)
Assessing pain and analgesia with a lidocaine-prilocaine emulsion in infants and toddlers during venipuncture. (1991) (144)
Cohort profile: the maternal-infant research on environmental chemicals research platform. (2013) (144)
Maternal and fetal outcome after invasive cervical cancer in pregnancy. (1991) (143)
Intratympanic Gentamicin for Menière's Disease: a Meta‐Analysis (2004) (143)
Hair cortisol and the risk for acute myocardial infarction in adult men (2011) (143)
Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis (2018) (142)
Risk of Suicide Following Deliberate Self-poisoning. (2015) (141)
Pregnancy outcome following in utero exposure to bisphosphonates. (2009) (140)
Incidence of Major Malformations in Infants following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study (2009) (139)
Folic acid food fortification is associated with a decline in neuroblastoma (2003) (139)
Population Baseline of Meconium Fatty Acid Ethyl Esters Among Infants of Nondrinking Women in Jerusalem and Toronto (2003) (138)
Determination of gestational cocaine exposure by hair analysis. (1989) (138)
Cyclosporine excretion into breast milk. (2003) (138)
Maternal and foetal outcome following Hodgkin's disease in pregnancy. (1992) (136)
Increased Use of Antidepressants in Canada: 1981–2000 (2002) (135)
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. (2013) (135)
From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. (2007) (135)
Methotrexate exposure prior to and during pregnancy. (1994) (135)
Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. (2008) (135)
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. (1990) (133)
Systematic evaluation of errors occurring during the preparation of intravenous medication (2008) (132)
Growth failure and bony changes induced by deferoxamine. (1992) (132)
A randomized, double-blind comparison of lumbar epidural and intravenous fentanyl infusions for postthoracotomy pain relief. Analgesic, pharmacokinetic, and respiratory effects. (1992) (131)
Morphine or Ibuprofen for Post-Tonsillectomy Analgesia: A Randomized Trial (2015) (131)
Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. (2005) (130)
A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis (2014) (130)
Directly measured second hand smoke exposure and asthma health outcomes (2005) (129)
Risk Factors for Long‐Term Outcome of Ifosfamide‐Induced Nephrotoxicity in Children (1999) (129)
Ribavirin in the treatment of SARS: A new trick for an old drug? (2003) (128)
Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. (1989) (126)
Maternal treatment with opioid analgesics and risk for birth defects. (2011) (125)
Tissue plasminogen activator for the treatment of thromboembolism in infants and children. (1991) (125)
Alcohol use and pregnancy consensus clinical guidelines. (2010) (124)
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis (2014) (124)
Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: a meta-analysis. (1998) (123)
Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression: Results From the Norwegian Mother and Child Cohort Study (2012) (123)
The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy (2007) (122)
Ontogeny of drug elimination by the human kidney (2006) (122)
Toward Standardization of Hair Cortisol Measurement: Results of the First International Interlaboratory Round Robin (2015) (122)
The reproductive effects of beta interferon therapy in pregnancy (2005) (121)
Transfer of insulin lispro across the human placenta: in vitro perfusion studies. (2003) (121)
Reliability and validity of the 4-item perceived stress scale among pregnant women: results from the OTIS antidepressants study. (2012) (121)
Prenatal Multivitamin Supplementation and Rates of Pediatric Cancers: A Meta‐Analysis (2007) (121)
Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department (2004) (120)
Prenatal exposure to misoprostol and vascular disruption defects: a case-control study. (2000) (120)
Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies (2000) (119)
Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. (2005) (119)
Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse (2003) (118)
Safety of the New Quinolones in Pregnancy (1994) (117)
Pregnancy outcome following maternal organic solvent exposure: a meta-analysis of epidemiologic studies. (1998) (117)
A Multicentre Prospective Controlled Study to Determine the Safety of Trazodone and Nefazodone Use during Pregnancy (2003) (117)
Pregnancy outcome after gestational exposure to amiodarone in Canada. (1995) (117)
Maternal cocaine use and cigarette smoking in pregnancy in relation to amino acid transport and fetal growth. (1999) (116)
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. (1996) (115)
Chickenpox in pregnancy: revisited. (2006) (114)
A multicenter, prospective study of fetal outcome following accidental carbon monoxide poisoning in pregnancy. (1991) (114)
Breast milk and cognitive development—the role of confounders: a systematic review (2013) (114)
Pregnancy outcome following first trimester exposure to chloroquine. (1991) (113)
A Method for Meta-Analysis of Epidemiological Studies (1988) (113)
Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. (2000) (113)
Polymorphism of the MDR1/ABCB1 C3435T drug‐transporter and resistance to anticonvulsant drugs: A meta‐analysis (2009) (113)
Characteristics of Opioid-Users Whose Death Was Related to Opioid-Toxicity: A Population-Based Study in Ontario, Canada (2013) (112)
Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. (1995) (112)
The Detection of Cortisol in Human Sweat: Implications for Measurement of Cortisol in Hair (2013) (111)
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. (2012) (111)
Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores (2005) (111)
Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety. (2006) (110)
Excretion of Fluoxetine and Its Metabolite, Norfluoxetine, in Human Breast Milk (1996) (109)
Critical Comparison of Novel and Existing Methods of Compliance Assessment During a Clinical Trial of an Oral Iron Chelator (1994) (108)
Prospective controlled study of hydroxyzine and cetirizine in pregnancy. (1997) (108)
Management of Multiple Sclerosis During Pregnancy and the Reproductive Years: A Systematic Review (2014) (108)
Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. (2000) (107)
Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. (1997) (107)
Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy. (1989) (107)
Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study (2015) (105)
Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. (2009) (105)
Hair Concentrations of Nicotine and Cotinine in Women and Their Newborn Infants (1994) (105)
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. (2007) (105)
The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. (2008) (105)
Risks of untreated depression during pregnancy. (2014) (104)
Neonatal paroxetine withdrawal syndrome (2001) (103)
Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. (2010) (102)
Effectiveness of sucrose analgesia in newborns undergoing painful medical procedures (2008) (102)
Does treatment with bisphosphonates endanger the human pregnancy? (2008) (101)
Drugs of abuse testing in meconium. (2006) (101)
Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. (1990) (101)
Assessing individual systemic stress through cortisol analysis of archaeological hair (2010) (101)
Psychosocial morbidity among women with nausea and vomiting of pregnancy: Prevalence and association with anti-emetic therapy (2000) (100)
A systematic review of the therapeutic effects of Reiki. (2009) (99)
Improving executive functioning in children with fetal alcohol spectrum disorders (2012) (99)
Risks of statin use during pregnancy: a systematic review. (2007) (99)
Designing pregnancy centered medications: drugs which do not cross the human placenta. (2006) (98)
Therapeutic drug monitoring principles in the neonate (1997) (98)
Toxic neonatal effects following maternal clomipramine therapy. (1991) (98)
Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis. (1998) (97)
Pregnancy outcome following gestational exposure to azithromycin (2006) (96)
Compliance with cyclosporine in adolescent renal transplant recipients (1997) (95)
Pediatric Medication Errors: Predicting and Preventing Tenfold Disasters (1994) (95)
Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? (2005) (95)
Preliminary Studies of the Effects of Extracorporeal Membrane Oxygenator on the Disposition of Common Pediatric Drugs (1993) (94)
Personal clinical history predicts antibiotic resistance of urinary tract infections (2018) (94)
Child neurodevelopmental outcome and maternal occupational exposure to solvents. (2004) (94)
Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide. (1993) (94)
Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use. (2008) (94)
Breast-Feeding During Maternal Use of Azathioprine (2006) (92)
Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. (2009) (92)
Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study (2013) (91)
Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities (2019) (91)
Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease (2010) (91)
Treatment of nausea and vomiting in pregnancy: an updated algorithm. (2007) (91)
Hair Analysis of Cocaine: Differentiation Between Systemic Exposure and External Contamination (1992) (91)
Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. (2011) (91)
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. (2008) (91)
A Pilot Pharmacokinetic and Antiangiogenic Biomarker Study of Celecoxib and Low-dose Metronomic Vinblastine or Cyclophosphamide in Pediatric Recurrent Solid Tumors (2006) (90)
Hepatitis B vaccine in pregnancy: maternal and fetal safety. (1991) (90)
Long-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs (2010) (90)
A prospective controlled multicentre study of clarithromycin in pregnancy. (1998) (90)
Use of Proton Pump Inhibitors During Pregnancy and Rates of Major Malformations: A Meta-Analysis (2002) (89)
Pregnancy outcome following first trimester exposure to sumatriptan (1998) (89)
Breast cancer resistance protein: mediating the trans-placental transfer of glyburide across the human placenta. (2008) (89)
A systematic review of the fetal safety of interferon alpha. (2012) (89)
PREGNANCY OUTCOME FOLLOWING MATERNAL USE OF THE NEW SELECTIVE SEROTONIN REUPTAKE INHIBITORS : A PROSPECTIVE CONTROLLED MULTICENTER STUDY (1998) (89)
Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes (2009) (88)
Pregnancy outcome post renal transplantation. (2002) (88)
Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. (1998) (88)
Using a Preprinted Order Sheet to Reduce Prescription Errors in a Pediatric Emergency Department: A Randomized, Controlled Trial (2005) (87)
Safety of Glyburide for Gestational Diabetes: A Meta-Analysis of Pregnancy Outcomes (2008) (87)
Fentanyl Pharmacokinetics and Hemodynamic Effects in Preterm Infants during Ligation of Patent Ductus Arteriosus (1985) (87)
Folic acid in pregnancy and fetal outcomes (2008) (87)
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. (2012) (86)
Maternal-Fetal Transport of Hypoglycaemic Drugs (2003) (86)
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care (2003) (86)
Neurodevelopment of adopted children exposed in utero to cocaine. (1994) (86)
Management of pain from heel lance with lidocaine-prilocaine (EMLA) cream: is it safe and efficacious in preterm infants? (1999) (86)
Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research (2011) (86)
Antidepressant use during pregnancy: the benefit-risk ratio. (2012) (85)
A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. (1990) (85)
Safety of gadolinium during pregnancy. (2006) (85)
The safety of quinolones--a meta-analysis of pregnancy outcomes. (2009) (83)
Gastric-outlet obstruction induced by prostaglandin therapy in neonates. (1992) (83)
Comparison of oral and intravenous administration of sodium bromide for extracellular water measurements. (1987) (83)
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. (2008) (83)
Fetal safety of letrozole and clomiphene citrate for ovulation induction. (2007) (83)
The fetal safety of benzodiazepines: an updated meta-analysis. (2011) (83)
Associations of hair cortisol concentration with self-reported measures of stress and mental health-related factors in a pooled database of diverse community samples (2014) (83)
A survey of physicians knowledge regarding awareness of maternal alcohol use and the diagnosis of FAS. (2002) (82)
Compliance assessed by the Medication Event Monitoring System. (1991) (82)
Major malformations with valproic acid. (2006) (82)
Predicting Breast Cancer by Applying Deep Learning to Linked Health Records and Mammograms. (2019) (82)
Simultaneous detection of seventeen drugs of abuse and metabolites in hair using solid phase micro extraction (SPME) with GC/MS. (2012) (82)
Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis. (2016) (82)
Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine). (2001) (82)
Glyburide and fetal safety; transplacental pharmacokinetic considerations. (2001) (82)
Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester. (1990) (82)
Single‐dose and steady‐state pharmacokinetics of celecoxib in children (2002) (82)
Iron-balance and dose-response studies of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients with sickle cell disease. (1994) (81)
Neonatal Pain-Related Stress and NFKBIA Genotype Are Associated with Altered Cortisol Levels in Preterm Boys at School Age (2013) (81)
Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions (2010) (81)
Milk Transfer and Neonatal Safety of Tacrolimus (2003) (81)
Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults (2014) (81)
Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. (2003) (81)
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia (1992) (80)
Alarming Prevalence of Fetal Alcohol Exposure in a Mediterranean City (2008) (80)
Morphine excretion in breast milk and resultant exposure of a nursing infant. (1990) (79)
Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. (2002) (79)
Clinical applications of hair testing for drugs of abuse--the Canadian experience. (2000) (79)
Proceedings From the American College of Rheumatology Reproductive Health Summit: The Management of Fertility, Pregnancy, and Lactation in Women With Autoimmune and Systemic Inflammatory Diseases (2015) (79)
Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. (2004) (79)
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity (2005) (79)
A Critical Review of the Topical Local Anesthetic Amethocaine (Ametop™) for Pediatric Pain (2005) (79)
Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia. (1992) (79)
Evaluating the efficacy of EMLA in alleviating pain associated with lumbar puncture; comparison of open and double-blinded protocols in children (1990) (79)
Effectiveness of Bupropion for Smoking Cessation During Pregnancy (2005) (78)
Medication errors in children. (2006) (78)
Amphotericin B Nephrotoxicity in Children (2004) (78)
Comparison of genome-wide and gene-specific DNA methylation between ART and naturally conceived pregnancies (2015) (77)
Prevalence of Fetal Ethanol Exposure in a Regional Population-Based Sample by Meconium Analysis of Fatty Acid Ethyl Esters (2008) (77)
Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy (2001) (77)
Lidocaine—Prilocaine Cream versus Tetracaine Gel for Procedural Pain in Children (2002) (76)
Toxic effects of atenolol consumed during breast feeding. (1989) (76)
Pharmacokinetics and adverse effects of amphotericin B in infants and children. (1988) (76)
The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. (2003) (76)
The Effects of Impaired Liver Function on the Elimination of Antineoplastic Agents (1992) (75)
Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia. (1990) (75)
Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. (2002) (74)
In vitro assessment of the ethanol-induced hepatotoxicity on HepG2 cell line. (1993) (74)
Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease (2003) (74)
Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade (2017) (74)
Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. (2003) (73)
Reproductive risks of binge drinking during pregnancy. (1996) (73)
Pregnancy Outcome Following Prenatal Exposure to Triptan Medications: A Meta‐Analysis (2015) (73)
Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy (2001) (72)
Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. (2001) (72)
Neonatal benzodiazepines exposure during breastfeeding. (2012) (72)
N‐Acetylcysteine prevents ifosfamide‐induced nephrotoxicity in rats (2008) (72)
Validation of self-reported smoking by analysis of hair for nicotine and cotinine. (1996) (72)
Economic burden of nausea and vomiting of pregnancy in the USA. (2013) (72)
Ifosfamide-induced nephrotoxicity in children: critical review of predictive risk factors. (1998) (71)
Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations. (2009) (71)
In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy. (2003) (71)
Fetal Safety of Drugs Used in the Treatment of Allergic Rhinitis (2005) (71)
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. (2009) (71)
Ocular Toxicity in Children Exposed in Utero to Antimalarial Drugs: Review of the Literature (2011) (71)
Safety of Insulin Glargine Use in Pregnancy: A Systematic Review and Meta-Analysis (2011) (71)
Influenza vaccination during pregnancy. (2002) (71)
Oral Antidiabetic Agents in Pregnancy and Lactation: A Paradigm Shift? (2007) (71)
The ontogeny of P-glycoprotein in the developing human blood–brain barrier: implication for opioid toxicity in neonates (2015) (71)
The Role of Social Media in Recruiting for Clinical Trials in Pregnancy (2013) (71)
Pregnancy outcome following rubella vaccination: A prospective controlled study (2004) (71)
Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. (2000) (71)
Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. (2010) (70)
Characteristics of pregnant women who engage in binge alcohol consumption. (1997) (70)
Safety and efficacy of panax ginseng during pregnancy and lactation. (2008) (70)
Effects of framing on teratogenic risk perception in pregnant women (2001) (69)
“Doctor, will that x-ray harm my unborn child?” (2008) (69)
Treating Allergic Rhinitis in Pregnancy (1999) (69)
Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update (2015) (69)
Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. (1999) (69)
The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology. (2010) (69)
Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. (1998) (68)
Large errors in the dosing of medications for children. (2002) (68)
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (2011) (68)
Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial (2016) (68)
Safety of infliximab use during pregnancy. (2011) (68)
775 PROBABLE EFFICACY OF HIGH DOSE SALICYLATE IN REDUCING CORONARY INVOLVEMENT IN KAWASAKI DISEASE (1985) (68)
The safety of omeprazole during pregnancy: a multicenter prospective controlled study. (1998) (68)
Pediatric Fentanyl Dosing Based on Pharmacokinetics during Cardiac Surgery (1984) (67)
Safety classification of herbal medicines used in pregnancy in a multinational study (2016) (67)
Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach (2006) (67)
Guidelines for maternal codeine use during breastfeeding. (2009) (67)
Hair cortisol concentrations in higher- and lower-stress mother-daughter dyads: A pilot study of associations and moderators. (2015) (67)
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling (2008) (67)
Fetal toxicology of environmental tobacco smoke. (1995) (67)
A novel index for expressing exposure of the infant to drugs in breast milk. (1994) (67)
Prevalence and severity of nausea and vomiting of pregnancy and effect of vitamin supplementation. (1999) (67)
Autism characteristics in children with fetal alcohol spectrum disorders (2013) (66)
Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis (2012) (66)
Prediction of Codeine Toxicity in Infants and Their Mothers Using a Novel Combination of Maternal Genetic Markers (2012) (65)
Effect of methotrexate on male fertility. (2003) (65)
Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada (2000) (65)
Iron Deposition in the Anterior Pituitary in Homozygous Beta-Thalassemia: MRI Evaluation and Correlation with Gonadal Function (2000) (65)
Reference Values for Hair Cotinine as a Biomarker of Active and Passive Smoking in Women of Reproductive Age, Pregnant Women, Children, and Neonates: Systematic Review and Meta-Analysis (2007) (65)
Pregnant Women's Beliefs About Medications—A Study Among 866 Norwegian Women (2010) (64)
Impact of hair-care products on FAEE hair concentrations in substance abuse monitoring (2011) (64)
Drug Labeling and Risk Perceptions of Teratogenicity: A Survey of Pregnant Canadian Women and Their Health Professionals (2000) (64)
The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk. (2002) (64)
Patch Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome (2009) (64)
The Safety of Higher Than Standard Dose of Doxylamine‐Pyridoxine (Diclectin®) for Nausea and Vomiting of Pregnancy (2001) (64)
Prenatal exposure to organic solvents and child neurobehavioral performance. (2001) (64)
Neurodevelopment of Children Exposed In Utero to Phenytoin and Carbamazepine Monotherapy (1994) (64)
Estimation of Fetal Exposure to Drugs of Abuse, Environmental Tobacco Smoke, and Ethanol (2002) (64)
A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn (1985) (63)
Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one in patients with thalassemia (1991) (63)
Long-Term Neurodevelopment of Children Exposed In Utero to Ciclosporin After Maternal Renal Transplant (2010) (63)
The Safety of Fetal Exposure to Proton-Pump Inhibitors During Pregnancy (2012) (63)
Transfer of Dabigatran and Dabigatran Etexilate Mesylate Across the Dually Perfused Human Placenta (2014) (63)
Passive smoking in children. Racial differences in systemic exposure to cotinine by hair and urine analysis. (1996) (63)
Novel Methods for the Detection of Drug and Alcohol Exposure During Pregnancy: Implications for Maternal and Child Health (2008) (62)
Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy (2011) (62)
The fetal safety of statins: a systematic review and meta-analysis. (2014) (62)
Meta-analytic review of the clinical effectiveness of oral deferiprone (L1) (1999) (62)
Defining a Lowest Observable Adverse Effect Hair Concentrations of Mercury for Neurodevelopmental Effects of Prenatal Methylmercury Exposure Through Maternal Fish Consumption: A Systematic Review (2009) (62)
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. (2007) (61)
Maternal Noncompliance with Antibiotics during Breastfeeding (1993) (61)
THE BURDEN OF PRENATAL EXPOSURE TO ALCOHOL: MEASUREMENT OF COST (2006) (61)
Maternal-fetal toxicology : a clinician's guide (2001) (61)
Pemoline‐associated fulminant liver failure: Testing the evidence for causation (1995) (60)
The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation (2011) (60)
Does paroxetine cause cardiac malformations? (2008) (60)
Combined analgesia and local anesthesia to minimize pain during circumcision. (2000) (60)
Pregnancy-induced changes in drug metabolism in epileptic women. (1991) (60)
Analgesic and Respiratory Effects of Epidural Sufentanil in Patients Following Thoracotomy (1988) (60)
Clinical Relevance of Therapeutic Drug Monitoring During Pregnancy (2002) (60)
The effectiveness of Teratology Information Services (TIS). (2007) (60)
Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings. (2015) (60)
Saliva Versus Blood Sampling for Therapeutic Drug Monitoring in Children: Patient and Parental Preferences and an Economic Analysis (1994) (60)
Accidental electric shock in pregnancy: a prospective cohort study. (1995) (60)
Evaluating the safety of St. John's Wort in human pregnancy. (2009) (59)
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: A therapeutic opportunity?* (2002) (59)
Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature (1999) (59)
Establishing Causality of CNS Depression in Breastfed Infants Following Maternal Codeine Use (2008) (59)
Prediction of Milk/Plasma Concentration Ratio of Drugs (2003) (59)
Lung tissue concentrations of nicotine in sudden infant death syndrome (SIDS). (2002) (59)
Development of Canadian screening tools for fetal alcohol spectrum disorder. (2008) (59)
The Pharmacokinetics of Alfentanil in Children (1987) (59)
Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. (1992) (59)
Neurodevelopment of children exposed in utero to treatment of maternal malignancy (2001) (58)
Safety and efficacy of ginkgo (Ginkgo biloba) during pregnancy and lactation. (2006) (58)
EFFICACY AND SAFETY OF LIDOCAINE-PRILOCAINE CREAM FOR PAIN DURING CIRCUMCISION (1997) (58)
Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience. (1997) (58)
Long-term outcomes following self-poisoning in adolescents: a population-based cohort study. (2015) (58)
Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants (1994) (58)
The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. (2009) (58)
Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. (1990) (58)
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers (2011) (58)
Liquid chromatography-tandem mass spectrometry for fatty acid ethyl esters in meconium: assessment of prenatal exposure to alcohol in two European cohorts. (2008) (58)
The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy (2013) (57)
Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. (1983) (57)
CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. (2013) (57)
Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study. (1992) (56)
Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth (2010) (56)
Hair analysis–a biological marker for passive smoking in pregnancy and childhood (1999) (56)
Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites. (2000) (56)
Pharmacokinetic disposition and clinical outcomes in infants and children receiving intravenous busulfan for allogeneic hematopoietic stem cell transplantation. (2007) (56)
Vision abnormalities in young children exposed prenatally to organic solvents. (2005) (56)
Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study. (2001) (56)
Transfer of Glyburide and Glipizide Into Breast Milk (2005) (56)
Vancomycin pharmacokinetics and dose recommendations for preterm infants (1987) (56)
Reliability and validity of observer ratings of pain using the visual analog scale (VAS) in infants undergoing immunization injections (2009) (55)
The Safety of Histamine 2 (H2) Blockers in Pregnancy: A Meta-analysis (2009) (55)
Nicotine and cotinine in maternal and neonatal hair as markers of gestational smoking. (1996) (55)
Clinical pharmacology and therapeutic drug monitoring in neonates and children. (1998) (55)
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL. (1995) (55)
Transfer of cocaine and benzoylecgonine across the perfused human placental cotyledon. (1994) (55)
An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children (1997) (55)
Effects of Perioperative Oral Amantadine on Postoperative Pain and Morphine Consumption in Patients after Radical Prostatectomy: Results of a Preliminary Study (2004) (55)
Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. (2008) (55)
Choice of Breastfeeding and Physicians' Advice: A Cohort Study of Women Receiving Propylthiouracil (1999) (54)
The protective effects of nausea and vomiting of pregnancy against adverse fetal outcome--a systematic review. (2014) (54)
Binge alcohol consumption by non-alcohol – dependent women during pregnancy affects child behaviour, but not general intellectual functioning; a prospective controlled study (2004) (54)
The safety of fluoxetine during pregnancy and lactation. (1996) (54)
Reporting bias in retrospective ascertainment of drug-induced embryopathy (1999) (54)
Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. (1994) (54)
Solid-phase microextraction for the detection of codeine, morphine and 6-monoacetylmorphine in human hair by gas chromatography-mass spectrometry. (2010) (54)
Leukemia and lymphoma in pregnancy. (2011) (54)
Intravenous paraldehyde for seizure control in newborn infants (1986) (54)
Current management of the neonatal abstinence syndrome: a critical analysis of the evidence. (1997) (54)
Pediatric uses of opioids. (1989) (54)
Risk of Hypospadias in Offspring of Women Using Loratadine during Pregnancy (2008) (53)
Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. (2003) (53)
Major Malformations Following Exposure to Nonsteroidal Antiinflammatory Drugs During the First Trimester of Pregnancy (2012) (53)
Insulin Glargine Safety in Pregnancy (2009) (53)
Medications That Can Be Fatal For a Toddler with One Tablet or Teaspoonful (2004) (53)
Natural health product–HIV drug interactions: a systematic review (2005) (53)
Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. (2007) (53)
Placental Handling of Fatty Acid Ethyl Esters: Perfusion and Subcellular Studies (2004) (53)
Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation. (2008) (53)
Hair concentrations of nicotine and cotinine in women and their newborn infants. (1995) (53)
Development of Contrast Sensitivity in Infants with Prenatal and Neonatal Thyroid Hormone Insufficiencies (2002) (53)
Maternal ginseng use associated with neonatal androgenization. (1990) (53)
Safety of first-trimester exposure to topical tretinoin: prospective cohort study (1997) (53)
Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. (1992) (52)
Medications which can kill a toddler with one tablet or teaspoonful. (1993) (52)
The effects of subcutaneous deferoxamine administration on renal function in thalassemia major. (1991) (52)
The management of nausea and vomiting of pregnancy and hyperemesis gravidarum--a 2013 update. (2013) (52)
Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction. (1986) (52)
Glyburide Transport Across the Human Placenta (2015) (52)
Folate fortification and supplementation--are we there yet? (2008) (52)
A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects. (1994) (52)
Physician compliance and relapse rates of acute lymphoblastic leukemia in children (1988) (51)
Breast Cancer Resistance Protein (BCRP)-Mediated Glyburide Transport: Effect of the C421A/Q141K BCRP Single-Nucleotide Polymorphism (2010) (51)
Pregnancy outcome following high doses of Vitamin E supplementation. (2005) (51)
Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns (2008) (51)
Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study (2012) (51)
Transfer of morphine across the human placenta and its interaction with naloxone. (1999) (51)
Bradycardia and hypotension following reperfusion with streptokinase (Bezold-Jarisch reflex): a sign of coronary thrombolysis and myocardial salvage. (1986) (51)
Steady state pharmacokinetics of mefloquine in long-term travellers. (1993) (51)
Rivaroxaban transfer across the dually perfused isolated human placental cotyledon. (2015) (51)
Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions (2014) (51)
Toxic digoxin-drug interactions: the major role of renal P-glycoprotein. (1998) (51)
Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. (1990) (50)
Self-reported and measured stress related responses associated with exposure to wind turbine noise. (2016) (50)
Prenatal exposure to mycophenolate mofetil: an updated estimate. (2010) (50)
Safety and efficacy of black cohosh (Cimicifuga racemosa) during pregnancy and lactation. (2006) (50)
Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition. (2004) (50)
Safety and efficacy of cranberry (vaccinium macrocarpon) during pregnancy and lactation. (2008) (50)
Pharmacokinetics of oral and intravenous bromide in normal volunteers. (1986) (50)
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? (2010) (50)
Health-related quality of life of Canadian children and youth prenatally exposed to alcohol (2006) (50)
Pregnancy outcomes following gabapentin use (2013) (50)
Fetal Exposure to Alcohol as Evidenced by Fatty Acid Ethyl Esters in Meconium in the Absence of Maternal Drinking History in Pregnancy (2004) (49)
The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program* (2007) (49)
The role of the placenta in drug transport and fetal drug exposure (2018) (49)
Tacrolimus-induced nephrotoxicity and genetic variability: a review. (2012) (49)
Unintended pregnancies and exposure to potential human teratogens. (2005) (49)
Neonatal Outcomes After Gestational Exposure to Nitrofurantoin (2013) (49)
Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum (2004) (48)
False-positive meconium test results for fatty acid ethyl esters secondary to delayed sample collection. (2012) (48)
The influence of hypothermia on the disposition of fentanyl — Human and animal studies (2004) (48)
Management of Kawasaki syndrome: a consensus statement prepared by North American participants of The Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988 (1989) (48)
Nicotine replacement therapy during pregnancy: recommended or not recommended? (2009) (48)
Outpatient treatment of croup with nebulized dexamethasone. (1996) (48)
Deferoxamine (Desferrioxamine) (1991) (48)
Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans? (2009) (48)
Methamphetamine detection in maternal and neonatal hair: implications for fetal safety (2006) (48)
Congenital varicella syndrome: the evidence for secondary prevention with varicella-zoster immune globulin (2011) (48)
CYP2D6 Polymorphisms and Codeine Analgesia in Postpartum Pain Management: A Pilot Study (2011) (48)
High-frequency oscillation in the rescue of infants with persistent pulmonary hypertension. (1988) (48)
Effect of Domperidone on Insufficient Lactation in Puerperal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2012) (48)
Arthropathy in thalassaemia patients receiving deferiprone (1994) (48)
Fetal response to maternally administered morphine. (2000) (48)
The safety of nitrofurantoin during the first trimester of pregnancy: meta‐analysis (1995) (48)
Glutathione Stability in Whole Blood: Effects of Various Deproteinizing Acids (2001) (48)
Prospective, controlled, multicentre study of loperamide in pregnancy. (2000) (47)
Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. (1997) (47)
A randomized prospective crossover trial of amlodipine in pediatric hypertension (2000) (47)
Measurement of Cortisol and Testosterone in Hair of Obese and Non-Obese Human Subjects (2014) (47)
Trends of Medication Errors in Hospitalized Children (2002) (47)
Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy. (2013) (47)
Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation. (2006) (47)
Prevalence of nausea and vomiting of pregnancy in the USA: a meta analysis. (2013) (47)
Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography. (1994) (47)
The effect of a short tutorial on the incidence of prescribing errors in pediatric emergency care. (2006) (47)
Effects of Antibacterials on the Unborn Child (2001) (47)
Acyclovir-induced nephrotoxicity: the role of the acyclovir aldehyde metabolite. (2011) (46)
First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis. (2015) (46)
Morphine pharmacokinetics in children following cardiac surgery: effects of disease and inotropic support. (1993) (46)
Influence of hypothermia on the pharmacokinetics of gentamicin and theophylline in piglets (1985) (46)
Piracetam therapy does not enhance cognitive functioning in children with down syndrome. (2001) (46)
Acute changes in renal function associated with deferoxamine therapy. (1990) (46)
Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications (2018) (46)
Safety of lidocaine-prilocaine cream in the treatment of preterm neonates. (1995) (46)
Topical 4% Amethocaine Gel Reduces the Pain of Subcutaneous Measles-Mumps-Rubella Vaccination (2004) (46)
Neonatal abstinence syndrome clinical practice guidelines for Ontario. (2012) (46)
Informed Consent in Pediatric Research (2015) (45)
Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid (1997) (45)
An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening. (2011) (45)
Hepatitis E infection during pregnancy. (2015) (45)
Cancer chemotherapy and pregnancy. (2013) (45)
Relative Efficacy of Amethocaine Gel and Lidocaine–Prilocaine Cream for Port-a-Cath Puncture in Children (1999) (45)
Management of Paracetamol Overdose (2001) (45)
Lead exposure, gestational hypertension and pre-eclampsia: A systematic review of cause and effect (2012) (45)
Accumulation of cocaine in maternal and fetal hair; the dose response curve. (1992) (45)
Understanding Fetal Alcohol Spectrum Disorders (FASDs): Toward Identification of a Behavioral Phenotype (2008) (45)
Pregnancy outcome following use of large doses of vitamin B6 in the first trimester (2006) (45)
Cost of fetal alcohol spectrum disorder in Canada. (2007) (45)
SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: Impact of a public health advisory and subsequent reports in the news media (2005) (45)
Audiologic profiles of children with Kawasaki disease. (1992) (44)
Hair Analysis of Fatty Acid Ethyl Esters in the Detection of Excessive Drinking in the Context of Fetal Alcohol Spectrum Disorders (2009) (44)
Valproic acid use in psychiatry: issues in treating women of reproductive age. (1998) (44)
The Effect of Detection Approaches on the Reported Incidence of Tenfold Errors (2006) (44)
Treating pain during pregnancy. (2010) (44)
Management of varicella infection (chickenpox) in pregnancy. (2012) (44)
Safety of first trimester exposure to histamine H2 blockers (1996) (44)
Pediatric Cancer Rates After Universal Folic Acid Flour Fortification In Ontario (2011) (44)
Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and diclectin. (2009) (44)
Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient (1992) (44)
Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review. (2012) (44)
Maturity of children to consent to medical research: the babysitter test. (1993) (44)
Cortisol and testosterone in hair as biological markers of systolic heart failure (2013) (44)
The transport of digoxin across the perfused human placental lobule. (1991) (44)
Non-Hodgkin's lymphoma and pregnancy. (1994) (44)
Hair cortisol as a biomarker of stress in mindfulness training for smokers. (2014) (44)
The Risk of Adverse Pregnancy Outcome After First Trimester Exposure to H1 Antihistamines: A Systematic Review and Meta-Analysis (2017) (44)
Glucose Metabolism Is Elevated and Vascular Resistance and Maternofetal Transfer Is Normal in Perfused Placental Cotyledons from Severely Growth-Restricted Fetuses (2000) (44)
Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. (2010) (43)
Neurodevelopment of children prenatally exposed to selective reuptake inhibitor antidepressants: Toronto sibling study. (2015) (43)
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. (2009) (43)
Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. (1999) (43)
The safety of methimazole and propylthiouracil in pregnancy: a systematic review. (2012) (43)
Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy. (2014) (42)
Interactions of Clobazam With Conventional Antiepileptics in Children (1997) (42)
The Effect of Acid-Reducing Pharmacotherapy on the Severity of Nausea and Vomiting of Pregnancy (2009) (42)
Hair as a biomarker of systemic exposure to polybrominated diphenyl ethers. (2014) (42)
Maternal obesity: Effects on pregnancy and the role of pre-conception counselling (2010) (42)
Bendectin/diclectin for morning sickness: a Canadian follow-up of an American tragedy. (1995) (42)
Anticonvulsants and Breast Feeding (2000) (42)
Steady‐State Pharmacokinetics of Isotretinoin and its 4‐Oxo Metabolite: Implications for Fetal Safety (1998) (42)
A model for the prediction of digoxin-drug interactions at the renal tubular cell level. (1998) (42)
Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials. (2007) (42)
Preemptive Treatment of Nausea and Vomiting of Pregnancy: Results of a Randomized Controlled Trial (2013) (41)
Influence of food on the bioavailability of oral methotrexate in children. (1995) (41)
Detection of polybrominated biphenyl ethers (PBDEs) in pediatric hair as a tool for determining in utero exposure. (2012) (41)
Determination of Gestational Cocaine Exposure by Hair Analysis (1990) (41)
Neurodevelopment of adopted children exposed in utero to cocaine: the Toronto Adoption Study. (2001) (41)
Prenatal hair development: implications for drug exposure determination. (2010) (41)
Perception of Teratogenic Risk and the Rated Likelihood of Pregnancy Termination: Association with Maternal Depression (2011) (41)
The digoxin-propafenone interaction: characterization of a mechanism using renal tubular cell monolayers. (1997) (41)
Pharmacokinetic predisposition to nicotine from environmental tobacco smoke: a risk factor for pediatric asthma. (1998) (41)
Effects of maternal occupational exposure to organic solvents on offspring visual functioning: a prospective controlled study. (2001) (41)
Cyclosporine and lactation: when the mother is willing to breastfeed. (2011) (41)
Identifying women who might benefit from higher doses of folic acid in pregnancy. (2012) (41)
Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age. (2009) (40)
Maternal Use of Venlafaxine Near Term: Correlation Between Neonatal Effects and Plasma Concentrations (2009) (40)
Use of the eutectic mixture of local anesthetics in young children for procedure-related pain. (1993) (40)
Examining the transplacental passage of apixaban using the dually perfused human placenta (2016) (40)
Diagnosis of fetal alcohol spectrum disorder (FASD): fatty acid ethyl esters and neonatal hair analysis. (2006) (40)
Detection and quantification of fatty acid ethyl esters in meconium by headspace-solid-phase microextraction and gas chromatography-mass spectrometry. (2009) (40)
Fetal exposure to isotretinoin-an international problem. (2008) (40)
The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells. (2007) (40)
Sequestration of fentanyl by the cardiopulmonary bypass (CPBP) (2004) (39)
Circulating Unmetabolized Folic Acid: Relationship to Folate Status and Effect of Supplementation (2012) (39)
Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta‐analysis (2015) (39)
Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis (2015) (39)
Therapeutic abortions due to severe morning sickness. Unacceptable combination. (1997) (39)
Pregnancy outcome and infant development following gestational cocaine use by social cocaine users in Toronto, Canada. (1992) (39)
The fetal safety of fluoxetine: a systematic review and meta-analysis. (2013) (39)
Assessing nicotine metabolism in pregnancy--a novel approach using hair analysis. (2004) (39)
Effects of age, gender and holding on pain response during infant immunization. (2004) (39)
Challenges for drug studies in children: CYP3A phenotyping as example. (2009) (39)
The perception of teratogenic risk by women with nausea and vomiting of pregnancy. (1999) (39)
The Toronto experience in diagnosing alcohol-related neurodevelopmental disorder: a unique profile of deficits and assets. (2002) (39)
Fetal Safety of Macrolides (2013) (39)
Urinary tract infections in pregnancy. (2008) (39)
A prospective-controlled study of pregnant veterinary staff exposed to inhaled anesthetics and x-rays. (2002) (38)
A Double‐Blind, Randomized, Placebo‐Controlled Trial of Eutectic Lidocaine/Prilocaine Cream 5% (EMLA)® for Analgesia Prior to Cryotherapy of Warts in Children and Adults (1998) (38)
Relationship Between Gestational Cocaine Use and Pregnancy Outcome: A Meta-Analysis (1992) (38)
A Method for Simultaneous Measurement of Cocaine and Nicotine in Neonatal Hair (1994) (38)
Hepatotoxicity of 6-mercaptopurine in childhood acute lymphocytic leukemia: pharmacokinetic characteristics. (1996) (38)
Initiation and duration of breast-feeding in women receiving antiepileptics. (1995) (38)
Determinants of Aciclovir-Induced Nephrotoxicity in Children (2008) (38)
Serum Concentrations, Efficacy, and Safety of a New, Intravenously Administered Varicella Zoster Immune Globulin in Pregnant Women (2002) (38)
Acetaminophen-induced toxicity to human epidermoid cell line A431 and hepatoblastoma cell line Hep G2, in vitro, is diminished by silymarin. (1995) (38)
Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. (2004) (38)
The Incidence of Prenatal Alcohol Exposure in Montevideo Uruguay As Determined by Meconium Analysis (2010) (38)
Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester (1990) (38)
Chronic Prenatal Ethanol Exposure and Increased Concentration of Fatty Acid Ethyl Esters in Meconium of Term Fetal Guinea Pig (2006) (38)
Measurement of drugs in neonatal hair; a window to fetal exposure. (1995) (38)
Recall bias of the symptoms of nausea and vomiting of pregnancy. (2004) (38)
A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk (2013) (38)
Awakenings: Using a popular movie to teach clinical pharmacology (1993) (37)
Possible indomethacin-aminoglycoside interaction in preterm infants. (1985) (37)
Screening and recording of alcohol use among women of child-bearing age and pregnant women. (2009) (37)
Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1). (1993) (37)
Novel approaches to the diagnosis of fetal alcohol spectrum disorder (2007) (37)
P450 Oxidoreductase *28 (POR*28) and Tacrolimus Disposition in Pediatric Kidney Transplant Recipients—A Pilot Study (2014) (37)
Social Perspective Taking and Empathy in Children with Fetal Alcohol Spectrum Disorders (2015) (37)
The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin study. (2001) (37)
Risk of Vaginal Bleeding and Postpartum Hemorrhage After Use of Antidepressants in Pregnancy: A Study From the Norwegian Mother and Child Cohort Study (2014) (37)
Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels. (2004) (37)
Safety of azathioprine use during pregnancy. (2011) (37)
Hair analysis as a marker for fetal exposure to maternal smoking. (1993) (37)
Drug-induced acute kidney injury in children. (2015) (37)
Biologic markers of pain in the vulnerable infant. (2002) (37)
Exposure to ionizing radiation during pregnancy: Perception of teratogenic risk and outcome (1991) (37)
Alcohol and Breast Feeding: Calculation of Time to Zero Level in Milk (2001) (37)
The effect of hair pigment on the incorporation of fatty acid ethyl esters (FAEE). (2009) (37)
Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): Implications for teratogenic risk (2003) (36)
Safety of tacrolimus in pregnancy. (2014) (36)
Effect of iron content on the tolerability of prenatal multivitamins in pregnancy (2008) (36)
A survey of pregnant women using isotretinoin. (2005) (36)
Lumbar epidural fentanyl infusions for post-thoracotomy patients: analgesic, respiratory, and pharmacokinetic effects. (1990) (36)
Myasthenia gravis during pregnancy. (2012) (36)
Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms (2003) (36)
Human Milk Biomonitoring Data: Interpretation and Risk Assessment Issues (2005) (36)
Evaluation of eutectic lidocaine/prilocaine cream (EMLA) for steroid joint injection in children with juvenile rheumatoid arthritis: a double blind, randomized, placebo controlled trial. (2003) (36)
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. (2010) (36)
Camphorated oil: still endangering the lives of Canadian children. (1995) (36)
Hair cortisol concentration is unaffected by basic military training, but related to sociodemographic and environmental factors (2015) (36)
Insulin Glargine Safety in Pregnancy: a Transplacental Transfer Study Short Title: Insulin glargine placental transfer (2009) (35)
Elimination kinetics of ethanol in pregnant women. (2004) (35)
Human hair cortisol analysis: comparison of the internationally-reported ELISA methods. (2013) (35)
P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. (1993) (35)
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation (2017) (35)
Risk Factors of Acute Kidney Injury in Critically Ill Children* (2016) (35)
Validation of the oral mucositis assessment scale in pediatric cancer (2007) (35)
Clinical Pharmacokinetic Significance of the Renal Tubular Secretion of Digoxin (1987) (35)
Acetylcholinesterase and butyrylcholinesterase activity in the human term placenta: implications for fetal cocaine exposure. (1994) (35)
Challenges to diagnosing colorectal cancer during pregnancy. (2009) (34)
Nausea and vomiting in pregnancy: a comparative European study. (1998) (34)
Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. (1998) (34)
The perception of teratogenic risk by women with nausea and vomiting of pregnancy (1999) (34)
Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries (2001) (34)
Neurocognitive Development of Children Following In-Utero Exposure to Labetalol for Maternal Hypertension: A Cohort Study Using a Prospectively Collected Database (2010) (34)
Interpretation of excessive serum concentrations of digoxin in children. (1985) (34)
Occupational exposure to mercury. What is a safe level? (1999) (34)
Significance of the endogenous digoxin‐like substance in infants and mothers (1984) (34)
Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies (2001) (34)
The safety of dextromethorphan in pregnancy : results of a controlled study. (2001) (34)
Nausea and Vomiting of Pregnancy: State of the Art 2000 (2000) (34)
Back to basics: understanding drugs in children: pharmacokinetic maturation. (2005) (34)
Chronopharmacology of methotrexate pharmacokinetics in childhood leukemia. (1992) (33)
Exposure to attention deficit hyperactivity disorder medications during pregnancy. (2007) (33)
Appendicitis during pregnancy. (2004) (33)
Assessment of visual functions following prenatal exposure to organic solvents. (2003) (33)
Review of a Home-Based Palliative Care Program for Children with Malignant and Non-Malignant Diseases (1997) (33)
The use of topical 5% imiquimod during pregnancy: a case series. (2006) (33)
Safety of procedural sedation in pregnancy. (2013) (33)
Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine. (2011) (33)
Insulin Detemir Does Not Cross the Human Placenta (2015) (33)
The "warfarin window" in pregnancy: the importance of half-life. (2010) (33)
Preconception counseling and women's compliance with folic acid supplementation. (1999) (33)
Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy (2016) (33)
Renal handling of cisplatin: interactions with organic anions and cations in the dog. (1991) (33)
Marijuana use and breastfeeding. (2005) (33)
Homocysteine, folate and pregnancy outcomes (2012) (33)
Postmortem redistribution of digoxin in rats. (1985) (32)
Biological markers of intrauterine exposure to cocaine and cigarette smoking. (1992) (32)
Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. (1998) (32)
Taking ACE inhibitors during pregnancy. Is it safe? (2002) (32)
Complications resulting from use of arterial catheters: retrograde flow and rapid elevation in blood pressure. (1985) (32)
Cocaine Detection in Maternal and Neonatal Hair: Implications to Fetal Toxicology (2007) (32)
Hair Cortisol as a Biomarker of Stress Among a First Nation in Canada (2013) (32)
Pregnancy and isotretinoin therapy (2013) (32)
A Comparison of Folic Acid Pharmacokinetics in Obese and Nonobese Women of Childbearing Age (2011) (32)
Midodrine efficacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. (1996) (32)
Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinate. (1994) (32)
Long‐Term Neurodevelopmental Risks in Children Exposed in Utero to Cocaine: The Toronto Adoption Study a (1998) (32)
The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). (1993) (32)
Clopidogrel use in children (2005) (32)
Neonatal screening for prenatal alcohol exposure: assessment of voluntary maternal participation in an open meconium screening program. (2012) (32)
The effect of distant reiki on pain in women after elective Caesarean section: a double-blinded randomised controlled trial (2011) (32)
Pain Perception and Effectiveness of the Eutectic Mixture of Local Anesthetics in Children Undergoing Venipuncture (1992) (31)
Association between moderate alcohol consumption during pregnancy and spontaneous abortion, stillbirth and premature birth: A meta-analysis (1998) (31)
Immortal time bias in drug safety cohort studies: spontaneous abortion following nonsteroidal antiinflammatory drug exposure. (2015) (31)
Vocal Biomarker Is Associated With Hospitalization and Mortality Among Heart Failure Patients (2020) (31)
Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. (2002) (31)
Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use. (2009) (31)
ATTITUDES AND PRACTICES OF PHYSICIANS AND NATUROPATHSTOWARD HERBAL PRODUCTS, INCLUDING USE DURING PREGNANCY AND LACTATION (2000) (31)
Comparison of deferoxamine pharmacokinetics between asymptomatic thalassemic children and those exhibiting severe neurotoxicity (1990) (31)
The first case of documented Covid-19 reinfection in Israel (2020) (31)
Serological Response to the BNT162b2 COVID-19 mRNA Vaccine in Adolescent and Young Adult Kidney Transplant Recipients (2021) (31)
Drug-induced aplastic anemia: pathogenesis and clinical aspects. (1990) (31)
Postmortem redistribution of morphine in rats. (1992) (30)
The transfer of pravastatin in the dually perfused human placenta. (2013) (30)
Noninvasive methods for drug measurement in pediatrics. (1997) (30)
Effects of maternal epilepsy on children's neurodevelopment (1995) (30)
The effects of cocaine and nicotine on amino acid transport across the human placental cotyledon perfused in vitro. (2000) (30)
Digoxin toxicity associated with amiodarone therapy in children. (1984) (30)
Codeine-related deaths: The role of pharmacogenetics and drug interactions. (2014) (30)
Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. (1999) (30)
Botulinum toxin type A in pregnancy. (2013) (30)
Alcohol exposure among pregnant women in sub-saharan Africa: a systematic review. (2013) (30)
Vancomycin pharmacokinetics in very low birth weight neonates. (1989) (30)
Effect of lidocaine-prilocaine cream on pain from subcutaneous injection. (1992) (30)
Cisplatin protein binding in pregnancy and the neonatal period. (1994) (30)
Association of In Utero Exposure to Polybrominated Diphenyl Ethers With the Risk of Hypospadias (2018) (30)
A differential approach for examining the behavioural phenotype of fetal alcohol spectrum disorders. (2011) (30)
Treatment of Epilepsy in Pregnancy (1999) (30)
A tubule cell model for ifosfamide nephrotoxicity. (2005) (30)
Cancer in pregnancy: identification of unanswered questions on maternal and fetal risks. (1990) (30)
Medication Safety in Pregnancy and Breastfeeding (2007) (30)
Drug transfer across the placenta. Considerations in treatment and research. (1994) (30)
Prevalence of fetal exposure to cocaine in Toronto, 1990-1991. (1994) (30)
Methotrexate embryopathy after exposure to low weekly doses in early pregnancy. (2014) (29)
Folic acid: the right dose. (2008) (29)
Renal ontogeny of ifosfamide nephrotoxicity. (2004) (29)
Use of healthy children as volunteers in drug studies: The ethical debate (2003) (29)
The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. (1997) (29)
Hypoxia associated with helium-oxygen therapy in neonates. (1985) (29)
Decreased theophylline clearance causing toxicity in children during viral epidemics. (1985) (29)
Pharmacokinetic determinants of 6‐mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia (1986) (29)
Can herbal products be used safely during pregnancy? Focus on echinacea. (2001) (29)
Vitamin E: The Evidence for Multiple Roles in Cancer (2003) (29)
Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation. (2012) (29)
Cultural and socio-economic conditions as factors contributing to chronic stress in sub-Saharan African communities. (2014) (29)
Pharmacokinetics in pregnancy; clinical significance. (2011) (29)
Unexpected alterations in fentanyl pharmacokinetics in children undergoing cardiac surgery: age related or disease related? (1986) (29)
Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans. (1998) (29)
Oral Morphine Weaning for Neonatal Abstinence Syndrome at Home Compared with In-Hospital: An Observational Cohort Study (2015) (29)
Opioid Detection in Maternal and Neonatal Hair and Meconium: Characterization of an At-Risk Population and Implications to Fetal Toxicology (2010) (28)
Congenital varicella syndrome in the third trimester (2005) (28)
Decreased protein binding of salicylates in Kawasaki disease. (1991) (28)
Medications for restless legs syndrome in pregnancy. (2008) (28)
Arylamine N-acetyltransferase activity of the human placenta. (1994) (28)
How physicians perceive and utilize information from a teratogen information service: The Motherisk Program (2004) (28)
Maternal and fetal outcome after breast cancer in pregnancy (1992) (28)
Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease. (1984) (28)
Characteristics of pregnant women exposed to cocaine in Toronto between 1985 and 1990. (1991) (28)
The pharmacogenetics of codeine pain relief in the postpartum period (2015) (28)
Neonatal hair analysis as a biomarker for in utero alcohol exposure. (2002) (28)
Use of Hair Analysis for Confirmation of Self-Reported Cocaine Use in Users with Negative Urine Tests (2001) (28)
Anticoagulation with sodium warfarin in children: effect of a loading regimen. (1988) (28)
Vitamin C-induced erythrocyte damage in premature infants. (1988) (28)
Neurodevelopment after in utero amiodarone exposure. (1999) (28)
Determinants of the need for hospital care among women with nausea and vomiting of pregnancy. (2001) (28)
Update on antidepressant use during breastfeeding. (2013) (28)
The Nephrotoxic Potential of Drugs and Chemicals Pharmacological Basis and Clinical Relevance (1989) (28)
Errors in computing drug doses. (1983) (28)
Obstetric and neonatal effects of drugs of abuse. (1990) (28)
Repetition of intentional drug overdose: a population-based study (2016) (27)
Baseline Measures of Fatty Acid Ethyl Esters in Hair of Neonates Born to Abstaining or Mild Social Drinking Mothers (2005) (27)
Should pregnant women be included in phase IV clinical drug trials? (2015) (27)
Celecoxib in Human Milk: A Case Report (2003) (27)
Comparing the effectiveness of TWEAK and T-ACE in determining problem drinkers in pregnancy. (2010) (27)
Cytochrome P450 2C9 genotype: Impact on celecoxib safety and pharmacokinetics in a pediatric patient (2005) (27)
Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report. (2012) (27)
Diurnal variation in the pharmacokinetics and myelotoxicity of mercaptopurine in children with acute lymphocytic leukemia. (1990) (27)
Association Between Use of Oral Contraceptives and Folate Status: A Systematic Review and Meta-Analysis. (2015) (27)
Safety of vancomycin with or without gentamicin in neonates. (1993) (27)
Rates of fetal alcohol exposure among newborns in a high-risk obstetric unit. (2010) (27)
Gender Differences in Drug Bioequivalence: Time to Rethink Practices (2013) (27)
The way women perceive teratogenic risk. (2007) (27)
Acyclovir Excretion in Human Breast Milk (1994) (27)
Endogenous Cortisol Predicts Decreased Loss Aversion in Young Men (2014) (27)
Pregnancy outcome after exposure to injectable ribavirin during embryogenesis (2005) (27)
Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. (1999) (27)
Mild maternal drinking and pregnancy outcome: perceived versus true risks. (1996) (27)
Interaction between digoxin and commonly coadministered drugs in children. (1985) (27)
Clinical Decision Support to Promote Safe Prescribing to Women of Reproductive Age: A Cluster-Randomized Trial (2012) (27)
Towards identifying a characteristic neuropsychological profile for fetal alcohol spectrum disorders. 1. Analysis of the Motherisk FASD clinic. (2013) (27)
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. (2009) (27)
The Safety of H2‐Blockers Use During Pregnancy (2010) (26)
The fetal safety of Levetiracetam: a systematic review. (2014) (26)
Oral iron chelation with deferiprone. (1997) (26)
Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis. (1994) (26)
Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study. (2007) (26)
Discontinuation syndrome following late pregnancy exposure to antidepressants. (2004) (26)
Fatty acid ethyl esters (FAEE); comparative accumulation in human and guinea pig hair as a biomarker for prenatal alcohol exposure. (2006) (26)
Effect of methotrexate treatment of ectopic pregnancy on subsequent pregnancy. (2011) (26)
FENTANYL ANESTHESIA FOR CARDIAC SURGERY IN CHILDRENa) FENTANYL-OXYGEN VS FENTANYL-N2O; b) RELATIONSHIP BETWEEN DRUG CONCENTRATIONS AND PHARMACODYNAMICS (1984) (26)
Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? (2004) (26)
Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits (2010) (26)
The Stability of a Ketamine-Morphine Solution (2002) (26)
A new, female-specific irritability rating scale. (2008) (26)
The safety of astemizole in pregnancy. (1996) (26)
Hemorrhoids in pregnancy. (2008) (26)
SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers? (2019) (25)
Effects of drugs on the fetus. (2005) (25)
Anticonvulsants and breast feeding: a critical review. (2000) (25)
Pruritus in pregnancy: treatment of dermatoses unique to pregnancy. (2013) (25)
Adherence and tolerability of iron-containing prenatal multivitamins in pregnant women with pre-existing gastrointestinal conditions (2009) (25)
A novel method for the evaluation of the severity of nausea and vomiting of pregnancy. (2001) (25)
N‐acetylcysteine as a Novel Prophylactic Treatment for Ifosfamide‐Induced Nephrotoxicity in Children: Translational Pharmacokinetics (2012) (25)
Simple Measurement of Captopril in Plasma by High‐Performance Liquid Chromatography with Ultraviolet Detection (1990) (25)
A crossover comparison of extended release felodipine with prolonged action nifedipine in hypertension. (1995) (25)
Home-Based Palliative Care for Children — Part 2: The Benefits of an Established Program (1990) (25)
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure (2018) (25)
Adolescent dimenhydrinate abuse: resurgence of an old problem. (1997) (25)
Potential Role of the Placenta in Fetal Alcohol Spectrum Disorder (2009) (25)
Correlation between drugs of abuse and alcohol by hair analysis: parents at risk for having children with fetal alcohol spectrum disorder. (2010) (25)
An investigation into variability in the therapeutic response to deferiprone in patients with thalassemia major. (1999) (25)
A pilot study of paternal drug exposure: the Motherisk experience (2009) (25)
Ethics of drug studies in infants: how many samples are required for accurate estimation of pharmacokinetic parameters in neonates? (1987) (25)
Safety and efficacy of echinacea (Echinacea angustafolia, e. purpurea and e. pallida) during pregnancy and lactation. (2006) (25)
Human Teratogens and Evidence-based Teratogen Risk Counseling: The Motherisk Approach (2007) (25)
A Randomized , Double-blind Comparison of Lumbar Epid , ural and Intrauenous Fentanyl Infusions for Postthoracotomy Pain Relief (25)
Pharmacotherapy and Pregnancy: Highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy (2009) (25)
Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis. (2015) (24)
Existence and severity of nausea and vomiting in pregnancy (NVP) with different partners (2007) (24)
Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. (1987) (24)
Toxoplasmosis during pregnancy. (2006) (24)
Studies of the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one in thalassemia patients. (1990) (24)
The perception of teratogenic risk of cocaine. (1992) (24)
Disposition of maternal ketoconazole in breast milk. (1995) (24)
Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study. (2012) (24)
Machine learning of big data in gaining insight into successful treatment of hypertension (2018) (24)
Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers. (2003) (24)
The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy (2009) (24)
Invasive mucormycosis in a non-immunocompromised patient. (1986) (24)
Rates of Fetal Polydrug Exposures in Methadone-Maintained Pregnancies from a High-Risk Population (2013) (24)
Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention (2009) (24)
Efficacy of Amlodipine in Pediatric Bone Marrow Transplant Patients (1998) (24)
Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency (2019) (24)
Phase I trial of a twice‐daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma (2001) (24)
Use of warfarin during pregnancy. (2002) (24)
Treating morning sickness in the United States--changes in prescribing are needed. (2014) (24)
Meconium Fatty Acid Ethyl Esters as Biomarkers of Late Gestational Ethanol Exposure and Indicator of Ethanol-Induced Multi-Organ Injury in Fetal Sheep (2013) (24)
Evaluation of the neurobehavioral screening tool in children with fetal alcohol spectrum disorders (FASD). (2014) (24)
Hair Nicotine: Cotinine Metabolic Ratio in Pregnant Women: A New Method to Study Metabolism in Late Pregnancy (2008) (24)
Machine learning algorithm for early detection of end-stage renal disease (2020) (24)
The differential diagnosis of fetal alcohol spectrum disorder. (2014) (24)
Diagnostic radiation in pregnancy: perception versus true risks. (2006) (24)
Cyclosporin A in the treatment of refractory immune thrombocytopenia purpura in children (2001) (24)
Apnea and Oxygen Desaturations in Children Treated with Opioids after Adenotonsillectomy for Obstructive Sleep Apnea Syndrome (2012) (24)
The three most common occupational exposures reported by pregnant women: an update. (1991) (23)
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. (2011) (23)
Is carbamazepine safe to take during pregnancy? (2012) (23)
Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program. (1999) (23)
Morphine-induced seizures in newborn infants. (1985) (23)
Ontogeny of Renal P-glycoprotein Expression in Mice: Correlation with Digoxin Renal Clearance (2005) (23)
Nausea and vomiting of pregnancy (NVP) and depression: cause or effect? (2011) (23)
Risks of untreated depression in pregnancy. (2014) (23)
Maternal cocaine use without evidence of fetal exposure. (1994) (23)
Transfer of glyburide and glipizide into breast milk. (2005) (23)
Heavily Smoking Women Who Cannot Quit in Pregnancy: Evidence of Pharmacokinetic Predisposition (2001) (23)
Tibial hemimelia and tetralogy of Fallot associated with first trimester exposure to amantadine. (1994) (23)
Assessment of systemic toxicity in children receiving chemotherapy with cyclosporine for sarcoma. (2000) (23)
Digoxin-carvedilol interactions in children. (2003) (23)
The efficacy of oral deferiprone in acute iron poisoning. (2000) (23)
Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). (2000) (23)
Periconceptional Folic Acid Supplementation: A New Indication for Therapeutic Drug Monitoring (2009) (23)
Lead exposure among mothers and their newborns in Toronto. (1990) (23)
Optimization of gentamicin therapy in very low birth weight infants. (1985) (23)
Can venlafaxine in breast milk attenuate the norepinephrine and serotonin reuptake neonatal withdrawal syndrome. (2006) (23)
Adverse effects in neonates exposed to SSRIs and SNRI in late gestation--Motherisk Update 2008. (2009) (23)
Evaluation of drug formularies for pediatric intensive care (2011) (23)
Pregnancy outcomes following first‐trimester exposure to topical retinoids: a systematic review and meta‐analysis (2015) (23)
P-glycoprotein in the Developing Human Brain: A Review of the Effects of Ontogeny on the Safety of Opioids in Neonates (2014) (23)
N‐Acetylcysteine for the Treatment of Clove Oil Induced Fulminant Hepatic Failure: Case Report and Review of the Literature (2004) (23)
Both Parental Psychopathology and Prenatal Maternal Alcohol Dependency Can Predict the Behavioral Phenotype in Children (2009) (23)
Exposure of pregnant women to ribavirin‐contaminated air: risk assessment and recommendations (1993) (22)
A simple and rapid HPLC method for the detection of glyburide in plasma original research communication (analytical). (2008) (22)
Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure? (2017) (22)
Validation of meconium fatty acid ethyl esters as biomarkers for prenatal alcohol exposure. (2004) (22)
Taking ACE inhibitors during early pregnancy: is it safe? (2007) (22)
Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. (2009) (22)
Hair biomarkers as measures of maternal tobacco smoke exposure and predictors of fetal growth. (2011) (22)
Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial (2015) (22)
The Role of Acetaldehyde in Pregnancy Outcome After Prenatal Alcohol Exposure (2001) (22)
Teratogenic determinants of first-trimester exposure to antiepileptic medications. (2011) (22)
Counseling about medication-induced birth defects with clinical decision support in primary care. (2013) (22)
Determinants of low serum concentrations of salicylates in patients with Kawasaki disease. (1988) (22)
Vancomycin-induced red man syndrome. (1990) (22)
Synthesis of fatty acid ethyl esters in mammalian tissues after ethanol exposure: a systematic review of the literature (2013) (22)
Drinking alcohol while breastfeeding. Will it harm my baby? (2002) (22)
Safety of 14C-UBT for diagnosis of Helicobacter pylori infection in pregnancy. (2009) (22)
The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis®/Diclectin®) for the Treatment of Nausea and Vomiting of Pregnancy (2014) (22)
A Double‐blind, Placebo‐controlled Trial of Transdermal Fentanyl after Abdominal Hysterectomy Analgesic, Respiratory, and Pharmacokinetic Effects (1994) (22)
Perpetuating fears: bias against the null hypothesis in fetal safety of drugs as expressed in scientific citations. (2011) (22)
Hair cortisol as a novel biomarker of HPA suppression by inhaled corticosteroids in children (2015) (22)
Toxoplasmosis and pregnancy. (2014) (22)
Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. (2007) (22)
Pharmacogenomics and active surveillance for serious adverse drug reactions in children. (2010) (22)
Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia (1990) (22)
N-acetylcysteine rescue protocol for nephrotoxicity in children caused by ifosfamide. (2013) (22)
Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled study. (1999) (21)
Clinical pharmacology of old age (2019) (21)
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145] (2006) (21)
Generic isotretinoin: a new risk for unborn children (2004) (21)
Preconception counseling for preventable risks. (2013) (21)
Comparing folic acid pharmacokinetics among women of childbearing age: single dose ingestion of 1.1 versus 5 MG folic acid. (2008) (21)
Asking the right questions to ascertain early childhood secondhand smoke exposures. (2012) (21)
A Clinical Guide to Reproductive and Developmental Toxicology (1993) (21)
Feasibility of pre-hospital fibrinolytic therapy in acute myocardial infarction. (1986) (21)
Oral morphine dosing predictions based on single dose in healthy children undergoing surgery (2017) (21)
Thrombocytopenia and megakaryocyte dysplasia: an adverse effect of valproic acid treatment. (2002) (21)
The Effects of Maternal Supplementation of Polyunsaturated Fatty Acids on Visual, Neurobehavioural, and Developmental Outcomes of the Child: A Systematic Review of the Randomized Trials (2012) (21)
Passive Environmental Exposure to Cocaine in Canadian Children (2009) (21)
Cocaine and the human fetus: the concept of teratophilia. (1993) (21)
Coexistence of Kaposi's sarcoma and chronic lymphocytic leukemia in the same lymph node. (1985) (21)
Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa? (2016) (21)
Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation. (2001) (21)
A Guinea Pig Model for the Identification of In Utero Alcohol Exposure Using Fatty Acid Ethyl Esters in Neonatal Hair (2005) (21)
Smoking in preeclamptic women is associated with higher birthweight for gestational age and lower soluble fms-like tyrosine kinase-1 levels: a nested case control study (2011) (21)
Clinical utilization of the neonatal hair test for cocaine: a four-year experience in Toronto. (1997) (21)
The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial. (2012) (21)
Prenatal multivitamins containing folic acid do not decrease prevalence of depression among pregnant women (2008) (21)
The transfer of 6-mercaptopurine in the dually perfused human placenta. (2011) (21)
Investigating the effects of low to moderate levels of prenatal alcohol exposure on child behaviour: a critical review. (2010) (21)
Heavy in utero ethanol exposure is associated with the use of other drugs of abuse in a high-risk population. (2010) (21)
Fetal and Neonatal Outcomes in Women Reporting Ingestion of Licorice (Glycyrrhiza uralensis) during Pregnancy (2013) (21)
The Effects of N-acetylcysteine on ifosfamide efficacy in a mouse xenograft model. (2012) (21)
Pediatric Clinical Pharmacology Studies in Chagas Disease (2009) (21)
Taking bisphosphonates during pregnancy. (2003) (21)
PHARMACOKINETIC CASE FOR GIVING 6-MERCAPTOPURINE MAINTENANCE DOSES AT NIGHT (1987) (21)
Systematic review of the effects of maternal hypertension in pregnancy and antihypertensive therapies on child neurocognitive development. (2013) (20)
Social problem solving in children with fetal alcohol spectrum disorders. (2012) (20)
Testosterone Concentrations in Hair of Hypogonadal Men With and Without Testosterone Replacement Therapy (2009) (20)
Clinical use of the Medication Event Monitoring System: A new window into pediatric compliance (1992) (20)
Feeling different: the experience of living with fetal alcohol spectrum disorder. (2011) (20)
Maternal spermicide use and adverse reproductive outcome: a meta-analysis. (1990) (20)
Iron poisoning in young children: association with the birth of a sibling. (2003) (20)
Mechanism of Anaphylactoid Reactions: Improper Preparation of High-Dose Intravenous Cyclosporine Leads to Bolus Infusion of Cremophor El and Cyclosporine (1997) (20)
Fetal outcome following roxithromycin exposure in early pregnancy (2006) (20)
Cocaine toxicity and isoflurane anesthesia: hemodynamic, myocardial metabolic, and regional blood flow effects in swine. (1996) (20)
Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful? (2013) (20)
Toward improved pregnancy labelling. (2010) (20)
Healthy Children As Subjects in Pharmaceutical Research (2003) (20)
Exposure to Nitrofurantoin During the First Trimester of Pregnancy and the Risk for Major Malformations (2013) (20)
Intravenous and Oral Propafenone for Treatment of Tachycardia in Infants and Children: Pharmacokinetics and Clinical Response (1998) (20)
Prospective assessment of pregnancy outcome following first trimester exposure to benzodiazepines (1993) (20)
A Surveillance Method for the Early Identification of Idiosyncratic Adverse Drug Reactions (2008) (20)
Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period. (2015) (20)
Antenatal sonography of fetal malformations associated with drugs and chemicals: a guide. (1987) (20)
Compliance with prenatal vitamins. Patients with morning sickness sometimes find it difficult. (2006) (20)
Is gentamicin ototoxic to the fetus? (2007) (20)
Fetal distribution of cocaine: case analysis. (1992) (20)
THE SOCIETY OF HAIR TESTING (2012) (20)
Relationship between the pharmacokinetics and the analgesic and respiratory pharmacodynamics of epidural sufentanil (1989) (20)
Maternal and neonatal characteristics following exposure to cocaine in Toronto. (1993) (20)
Experience with misoprostol therapy for NSAID gastropathy in children. (1995) (20)
Cisapride Use During Human Pregnancy (A Prospective, Controlled Multicenter Study) (1997) (20)
Bias in maternal reports of smoking during pregnancy associated with fetal distress. (2001) (20)
Safe use of valproic acid during pregnancy. (1999) (20)
Radiologic features of gastric outlet obstruction in infants after long-term prostaglandin administration (2005) (20)
Medication Errors in Paediatrics (2000) (20)
Hair cortisol as a biomarker of stress in the 2011 Libyan war. (2014) (20)
Trastuzumab treatment for breast cancer during pregnancy. (2008) (20)
Attitudes and practices of physicians and naturopaths toward herbal products, including use during pregnancy and lactation. (2000) (19)
Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients. (1993) (19)
The epidemiology of sleep disorders in Israel: results from a population-wide study. (2019) (19)
Fetal risks of maternal pharmacotherapy: identifying signals. (2011) (19)
Treating the common cold during pregnancy. (2008) (19)
Clinical course and pharmacokinetics following a massive overdose of amphotericin B in a neonate. (1990) (19)
Chronic Use of β-Blockers and the Risk of Parkinson’s Disease (2019) (19)
The dissociation between aminoglycoside serum concentrations and nephrotoxicity. (1988) (19)
Sulfonylurea intoxication at a tertiary care paediatric hospital. (2010) (19)
Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada. (1989) (19)
Hypoglycemia in a healthy toddler. (2009) (19)
Is the use of letrozole to induce ovulation teratogenic? (2008) (19)
Are the new SSRIs safe for pregnant women? (1998) (19)
Ethical framework for observational studies of medicinal drug exposure in pregnancy. (2002) (19)
Fish consumption in pregnancy and fetal risks of methylmercury toxicity. (2010) (19)
Maternal cocaine use during breastfeeding. (2012) (19)
Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis. (2015) (19)
Bias against the null hypothesis in maternal‐fetal pharmacology and toxicology (1997) (19)
Taking St John's wort during pregnancy. (2003) (19)
Foetal alcohol spectrum disorder: identifying the neurobehavioural phenotype and effective interventions (2014) (19)
Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe? (2012) (19)
A simple way to improve the chances for acceptance of your scientific paper. (1986) (19)
Human placental transfer and metabolism of p-aminobenzoic acid. (1994) (19)
Alcohol consumption among women. (2013) (19)
Maternal and obstetric effects of prenatal drug exposure. (1999) (19)
Effects of indomethacin on digoxin pharmacokinetics in preterm infants. (1984) (19)
Building Causal Graphs from Medical Literature and Electronic Medical Records (2019) (19)
Labetalol for hypertension in pregnancy (2015) (19)
Bias Toward the Null Hypothesis in Pregnancy Drug Studies That Do Not Include Data on Medical Terminations of Pregnancy: The Folic Acid Antagonists (2012) (18)
The transfer of ethyl glucuronide across the dually perfused human placenta. (2013) (18)
Warfarin Embryopathy Following Low-Dose Maternal Exposure (2005) (18)
Pregnant women's perception of risk with use of the H1N1 vaccine. (2011) (18)
Discordance between physical symptoms versus perception of severity by women with nausea and vomiting in pregnancy (NVP) (2002) (18)
Iphosphamide-induced nephrotoxicity in children (1992) (18)
Chronic Cocaine Exposure in a Toddler Revealed by Hair Test (2007) (18)
Putative Association of ABCB1 2677G>T/A With Oxycodone-Induced Central Nervous System Depression in Breastfeeding Mothers (2013) (18)
Maternal methamphetamine use in pregnancy and long-term neurodevelopmental and behavioral deficits in children. (2014) (18)
Comparison of Mortality and Comorbidity Rates Between Holocaust Survivors and Individuals in the General Population in Israel (2019) (18)
Evidence-based pain management for infants. (1998) (18)
Use of hypoglycemic drugs during lactation. (2009) (18)
Patterns of paediatric analgesic use in Africa: a systematic review (2012) (18)
Investigating the potential role of multi-drug resistance protein (MRP) transporters in fetal to maternal glyburide efflux in the human placenta (2008) (18)
A review of substance abuse monitoring in a social services context: a primer for child protection workers. (2010) (18)
Incidence of prenatal alcohol exposure in Prince Edward Island: a population-based descriptive study. (2014) (18)
Immune function in patients with β thalassaemia receiving the orally active iron‐chelating agent deferiprone (1997) (18)
No. 245-Alcohol Use and Pregnancy Consensus Clinical Guidelines. (2017) (18)
Safety of colchicine therapy during pregnancy. (2003) (18)
Hair cortisol as a hypothalamic-pituitary-adrenal axis biomarker in pregnant women with asthma: a retrospective observational study (2016) (18)
New antidepressants in pregnancy. (2004) (18)
Ontogeny of midazolam glucuronidation in preterm infants (2009) (18)
Unintended pregnancy during radiotherapy for cancer (2009) (18)
Acute Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium (2015) (18)
Hair methylmercury: a new indication for therapeutic monitoring. (2010) (18)
Agreement Between the Fatty Acid Ethyl Ester Hair Test for Alcohol and Social Workers' Reports (2010) (18)
Pregnancy outcome after exposure to oral contraceptives during the periconceptional period (2008) (18)
Study on circadian variation in folate pharmacokinetics. (2005) (17)
Health Canada advisory on domperidone should I avoid prescribing domperidone to women to increase milk production [corrected]? (2012) (17)
Fetal and perinatal exposure to drugs and chemicals: novel biomarkers of risk. (2014) (17)
Therapeutic drug monitoring principles in the neonate. National Academy of CLinical Biochemistry. (1997) (17)
Estimating the Economic Costs of Antidepressant Discontinuation during Pregnancy (2009) (17)
Prevalence of renal dysfunction in tacrolimus‐treated pediatric transplant recipients: A systematic review (2013) (17)
Methadone exposure during lactation. (2008) (17)
Pharmacological Treatment of Disruptive Behavior in Children with Fetal Alcohol Spectrum Disorder (2015) (17)
Captopril pharmacokinetics, blood pressure response and plasma renin activity in normotensive children with renal scarring. (1991) (17)
Effect of Liposomal Lidocaine and Sucrose Alone and in Combination for Venipuncture Pain in Newborns (2011) (17)
Medication Safety: Occurrence and Impact of Unanticipated Variation in Intravenous Methotrexate Dosing (2006) (17)
Electric shock during pregnancy. (2003) (17)
Correlation of morphine sulfate in blood plasma and saliva in pediatric patients. (1997) (17)
Teratogenicity of lamotrigine. (2007) (17)
Metformin use during the first trimester of pregnancy. Is it safe? (2006) (17)
Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B*1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms. (2011) (17)
Pharmacological Risk Factors for Amphotericin B Nephrotoxicity in Children (2007) (17)
Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats (2005) (17)
Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. (2003) (17)
Sources of bias in signals of pharmaceutical safety in pregnancy. (2010) (17)
Omega-3 fatty acid supplementation during pregnancy: for mother, baby, or neither? (2007) (17)
In vitro testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. (2009) (17)
Evaluation of the Oral Iron Chelator 1,2‐Dimethyl‐3‐hydroxypyrid‐4‐one (L1) in Iron‐Loaded Patients a (1990) (17)
Evaluation of a New Method for the Prevention of Neonatal Anemia (1989) (16)
Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov (2014) (16)
Exposure to sibutramine during pregnancy: a case series. (2004) (16)
The Effects of Cardiac Transplantation and Cyclosporine Therapy on Digoxin Pharmacokinetics (1992) (16)
Conclusions and Recommendations of the Expert Panel: Technical Workshop on Human Milk Surveillance and Biomonitoring for Environmental Chemicals in the United States (2005) (16)
A high-performance liquid chromatographic method for the measurement of the iron chelator 1,2-dimethyl-3-hydroxypyridin-4-one in human plasma. (1991) (16)
Use of proton pump inhibitors during pregnancy and breastfeeding. (2006) (16)
Vancomycin dosing in preterm infants: prospective verification of new recommendations. (1987) (16)
Home–Based Palliative Care for Children (1990) (16)
Acute liver failure after recommended doses of acetaminophen in patients with myopathies (2011) (16)
International practices in the provision of teratology information: a survey of international teratogen information programmes and comparisons with the North American model. (2010) (16)
Clinical use of meconium fatty acid ethyl esters for identifying children at risk for alcohol-related disabilities: the first reported case. (2012) (16)
Outcome of pregnancy after first trimester exposure to H2 receptor antagonists. (1991) (16)
Use of Clinical Pharmacists to Prevent Medication Errors in Children (1991) (16)
The effect of ascertainment bias in evaluating gestational antidepressant exposure. (2011) (16)
New Methods for Neonatal Drug Screening (2003) (16)
Predictors of Prenatal Multivitamin Adherence in Pregnant Women (2009) (16)
Bioavailability of a pediatric amlodipine suspension (2003) (16)
Neuroblastoma after prenatal exposure to phenytoin: cause and effect? (1989) (16)
Smoking cessation therapy during pregnancy. (2012) (16)
Is caffeine consumption safe during pregnancy? (2013) (16)
Contamination of Antibiotics Resulting in Severe Pediatric Methadone Poisoning (1999) (16)
Trimethoprim-sulfonamide combination therapy in early pregnancy. (2003) (15)
Estimating the neurocognitive effects of an early intervention program for children with prenatal alcohol exposure. (2009) (15)
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach. (2010) (15)
Cocaine abuse during pregnancy. (2014) (15)
Ischemic colitis in chronic intermittent peritoneal dialysis. (1984) (15)
In Vitro Testing for the Diagnosis of Anticonvulsant Hypersensitivity Syndrome (2009) (15)
Maternal obesity and risk of neural tube defects. (2001) (15)
Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity. (2011) (15)
Hair-Normalized Cortisol Waking Response as a Novel Biomarker of Hypothalamic-Pituitary-Adrenal Axis Activity following Acute Trauma: A Proof-of-Concept Study with Pilot Results (2013) (15)
Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents. (2003) (15)
Ceftriaxone-Induced Immune Hemolytic Anemia (2014) (15)
Taking ginger for nausea and vomiting during pregnancy. (2002) (15)
Screening for children's exposure to environmental tobacco smoke in a pediatric primary care setting. (2005) (15)
Examination of sex differences in fatty acid ethyl ester and ethyl glucuronide hair analysis. (2014) (15)
The Use of Glyburide in Gestational Diabetes - An Ideal Example of “Bench to Bedside” (2001) (15)
Exposure to fifth disease in pregnancy. (2009) (15)
Comparing pyridoxine and doxylamine succinate‐pyridoxine HCl for nausea and vomiting of pregnancy: A matched, controlled cohort study (2015) (15)
The incidence of nausea and vomiting of pregnancy (NVP): a comparison between depressed women treated with antidepressants and non-depressed women. (2006) (15)
Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy (2017) (15)
Establishing Causality in Pediatric Adverse Drug Reactions (2007) (15)
Outcome of children exposed In utero to fluoxetine: A critical review (1998) (15)
Associations Among Mother–Child Contact, Parenting Stress, and Mother and Child Adjustment Related to Incarceration (2015) (15)
Investigating the Use of Hair to Assess Polybrominated Diphenyl Ether Exposure Retrospectively (2014) (15)
Active and passive tobacco smoke exposure: a comparison of maternal and child hair cotinine levels. (2004) (15)
Higher Cortisol Predicts Less Improvement in Verbal Memory Performance after Cardiac Rehabilitation in Patients with Coronary Artery Disease (2013) (15)
Pharmacokinetics of ethanol in the maternal-fetal unit. (2013) (15)
Monitoring and avoiding drug and chemical teratogenicity. (1986) (15)
Fetal exposure to polybrominated diphenyl ethers and the risk of hypospadias: focus on the congeners involved. (2019) (15)
Efficacy of deferiprone in the treatment of acute iron intoxication in rats. (1996) (15)
The Effectiveness of Folate-Fortified Oral Contraceptives in Maintaining Optimal Folate Levels to Protect Against Neural Tube Defects: A Systematic Review. (2015) (15)
The Leading Concerns of American Women with Nausea and Vomiting of Pregnancy Calling Motherisk NVP Helpline (2013) (15)
Towards identifying a characteristic neuropsychological profile for fetal alcohol spectrum disorders. 2. Specific caregiver-and teacher-rating. (2013) (15)
The feasibility of using EMLA (eutectic mixture of local anaesthetics) cream in pediatric outpatient clinics. (1990) (15)
Salivary measurement of deferiprone concentrations and correlation with serum levels. (1997) (15)
Contact dermatitis and bradycardia in a preterm infant given tetracaine 4% gel. (2006) (15)
Universal Screening for Prenatal Alcohol Exposure: A Progress Report of a Pilot Study in the Region of Grey Bruce, Ontario (2010) (15)
Development of a machine learning algorithm for early detection of opioid use disorder (2020) (14)
An unusual skin exposure to copper; clinical and pharmacokinetic evaluation. (1988) (14)
Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors. (2009) (14)
Low-molecular-weight heparins during pregnancy. (2005) (14)
Effect of endogenous digoxin-like substances on the interpretation of high concentrations of digoxin in children. (1990) (14)
Fetal outcome following intrauterine amantadine exposure. (1991) (14)
A SURVEY OF WOMEN'S ATTITUDES CONCERNING HEALTHY LIFESTYLE CHANGES PRIOR TO PREGNANCY (2006) (14)
Chronic HPA axis response to stress in temporomandibular disorder. (2013) (14)
Identifying the neurobehavioral phenotype of fetal alcohol spectrum disorder in young children. (2013) (14)
Modulation of Celecoxib Pharmacokinetics by Food in Pediatric Patients (2005) (14)
Organization and efficacy of a therapeutic drug monitoring consultation service in a pediatric hospital. (1985) (14)
Assisted reproductive technology and the risk of pediatric cancer: A population based study and a systematic review and meta analysis. (2019) (14)
Tdap vaccination during pregnancy to reduce pertussis infection in young infants. (2013) (14)
Seawater desalination and serum magnesium concentrations in Israel. (2017) (14)
Folic acid and prevention of neural tube defects: a study of Canadian mothers of infants with spina bifida. (1996) (14)
Lead exposure during breastfeeding. (2008) (14)
Fluconazole use during breastfeeding. (2015) (14)
Oral hypoglycemic therapy: Understanding the mechanisms of transplacental transfer (2010) (14)
Pharmacokinetics of intravenous clindamycin in newborn infants. (1986) (14)
The Effects of Alcohol on The Fetal BrainThe Central Nervous System Tragedy (1998) (14)
Pharmacokinetics of fentanyl in children with renal disease. (1984) (14)
Ionizing radiation during pregnancy. (2003) (14)
Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study. (2016) (14)
Medications used in the treatment of disruptive behavior in children with FASD--a guide. (2015) (14)
The In Vitro Platelet Toxicity Assay (iPTA): A Novel Approach for Assessment of Drug Hypersensitivity Syndrome (2011) (14)
No. 274-Management of Varicella Infection (Chickenpox) in Pregnancy. (2018) (14)
Reduction of platelet counts induced by mechanical ventilation in newborn infants. (1987) (14)
Treating the mother – protecting the unborn: The safety of hypoglycemic drugs in pregnancy (2008) (14)
Intravenous administration of alpha-galactosyl carbohydrates reduces in vivo baboon serum cytotoxicity to pig kidney cells and transplanted pig hearts. (1994) (14)
Long-term neurodevelopmental risks in children exposed in utero to cocaine. The Toronto Adoption Study. (1998) (14)
Deviations from Typical Developmental Trajectories Detectable at 9 Months of Age in Low Risk Children Later Diagnosed with Autism Spectrum Disorder (2018) (14)
Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin (2009) (14)
Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age. (2009) (14)
Tenfold errors in drug dosage. (1988) (14)
Cancer in Pregnancy: Maternal and Fetal Risks: Specific tumors during pregnancy (1996) (14)
“A patient like me” – An algorithm-based program to inform patients on the likely conditions people with symptoms like theirs have (2019) (14)
Measuring a toddler's mouthful: toxicologic considerations. (2003) (14)
Corticosteroids‐Salicylate Interaction in a Case of Juvenile Rheumatoid Arthritis (1987) (13)
Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS. (2009) (13)
Motherisk update. Is ondansetron safe for use during pregnancy? (2012) (13)
High dose folic acid during pregnancy and the risk of autism; The birth order bias: a nested case-control study. (2019) (13)
The pharmacokinetics of extended release felodipine in children (1996) (13)
Diagnosing intrauterine exposure to cocaine by hair testing: six years of clinical use. (1998) (13)
Prolonged exposure to angiotensin-converting enzyme inhibitors during pregnancy. Fetal toxicity could be reversible. (2005) (13)
Response to hepatitis B immunization in children with hemophilia: relationship to infection with human immunodeficiency virus type 1. (1990) (13)
Reproducibility of medical information obtained via the telephone vs personal interview. (1999) (13)
Alcohol-induced behavioural problems in fetal alcohol spectrum disorders versus confounding behavioural problems. (2012) (13)
Women's perception of teratogenic risk. (1991) (13)
Occupational exposure to inhaled anesthetic. Is it a concern for pregnant women? (2000) (13)
Interaction between digoxin and propafenone in children. (1990) (13)
Hepatitis A infection during pregnancy. (2015) (13)
Fetal and neonatal outcomes in women taking domperidone during pregnancy (2013) (13)
The role of VariZIG in pregnancy (2013) (13)
Hypoglycemics: Pharmacokinetic Considerations During Pregnancy (2009) (13)
The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review. (2016) (13)
The fetal safety of clomiphene citrate: a population‐based retrospective cohort study (2017) (13)
Recent increases in numbers and risk of fatalities in young children ingesting iron preparations. (1994) (13)
Exposure to ionizing radiation during pregnancy: perception of teratogenic risk and outcome. (1991) (13)
Rarity of systemic lupus erythematosus after oral iron chelator L1 (1991) (13)
Outcomes of infants exposed to multiple antidepressants during pregnancy: results of a cohort study. (2011) (13)
Maternal Thyroid Disorders and Risk of Autism Spectrum Disorder in Progeny (2020) (13)
The generalizability of trial data; a comparison of β-blocker trial participants with a prospective cohort of women taking β-blockers in pregnancy (2001) (13)
Comparison of the pharmacokinetics of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in healthy volunteers, with and without co-administration of ferrous sulfate, to thalassemia patients. (1993) (13)
Caffeine during pregnancy? In moderation. (2000) (13)
Pregnancy outcome after exposure to the probiotic Lactobacillus in early pregnancy (2012) (13)
Doxorubicin in Lymphoma: Association Between Pharmacokinetic Variability and Clinical Response (2010) (13)
Increasing folate supplementation for selected groups of Canadian women. (2007) (13)
Sedating drugs and breastfeeding. (2015) (13)
Selective serotonin reuptake inhibitors and malformations: case closed? (2013) (13)
Cancer chemotherapy in young children: Challenges and solutions (2007) (13)
Fetal alcohol spectrum disorder - New diagnostic initiatives. (2002) (13)
Are infants exposed to methadone in utero at an increased risk for mortality? (2012) (13)
Sugar substitutes during pregnancy. (2014) (12)
Celiac disease during pregnancy. (2004) (12)
A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events (2017) (12)
Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina. (2009) (12)
Fetal safety of calcium channel blockers. (2012) (12)
Hyperthyroidism during pregnancy. (2009) (12)
Pharmacokinetic studies of nifedipine and digoxin co-administration. (1986) (12)
Therapeutic levetiracetam monitoring during pregnancy: “mind the gap” (2019) (12)
Evaluation of Therapeutic Drug Monitoring of Methotrexate in Saliva of Children with Rheumatic Diseases (1995) (12)
The fetal safety of hydrocortisone-pramoxine (Proctofoam-HC) for the treatment of hemorrhoids in late pregnancy. (2011) (12)
The pharmacokinetics and pharmacodynamics of the oral iron chelator deferiprone (L1) in relation to hemoglobin levels. (1996) (12)
The bentiromide test using plasma p-aminobenzoic acid for diagnosing pancreatic insufficiency in young children. The effect of two different doses and a liquid meal. (1991) (12)
Hyperemesis gravidarum-Is it a cause of abnormal fetal brain development? (2018) (12)
Hearing in children with fetal alcohol spectrum disorder (FASD). (2007) (12)
Use of the nicotine patch by pregnant women. (1999) (12)
Effects of prenatal exposure to marijuana. (2001) (12)
Inactive pharmaceutical ingredients : implications for pregnancy. (2007) (12)
Therapeutic choices for nausea and vomiting of pregnancy: a critical review of a systematic review. (2011) (12)
Are current pediatric dose recommendations for intravenous theophylline appropriate? (1993) (12)
Anorexia nervosa during pregnancy. (2003) (12)
A Randomized Trial to Evaluate the Effect of Two Topical Anesthetics on Pain Response During Frenotomy in Young Infants (2016) (12)
Acute iron intoxication: significant differences between sexes. (1997) (12)
Continuing drug therapy while breastfeeding. Part 1. Common misconceptions of patients. (1999) (12)
Textbook of ethics in pediatric research (1993) (12)
The detection and quantification of ethyl glucuronide in placental tissue and placental perfusate by headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry. (2012) (12)
Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature. (2011) (12)
Discrepancy between CYP2D6 phenotype and genotype derived from post-mortem dextromethorphan blood level. (2000) (12)
Diurnal variation of methotrexate disposition in children with acute leukaemia (2004) (12)
Risk of varicella infection during late pregnancy. (2003) (12)
Motherisk--a new approach to antenatal counselling of drug/chemical exposure. (1986) (12)
Pregnancy outcome following opioid exposure: A cohort study (2019) (12)
The Effect of Amitriptyline, Gabapentin, and Carbamazepine on Morphine-Induced Hypercarbia in Rabbits (2008) (12)
Lithium and pregnancy (1992) (12)
Safety of using montelukast during pregnancy. (2010) (12)
Pregnancy and commonly used drugs in hematology practice. (2010) (12)
SSRIs and persistent pulmonary hypertension of the newborn (2011) (12)
Evaluation and Counseling of Teratogenic Risk: The Motherisk Approach (1993) (12)
When a cocaine-using mother wishes to breastfeed: proposed guidelines. (2005) (12)
Environmental exposures and fetal growth: the Haifa pregnancy cohort study (2018) (12)
Establishing causality in pediatric adverse drug reactions: use of the Naranjo probability scale. (2007) (11)
Effects of quinidine on the renal tubular and biliary transport of digoxin: in vivo and in vitro studies in the dog. (1988) (11)
Evaluating External Contamination of Polybrominated Diphenyl Ethers in Human Hair: Clinical and Research Implications (2015) (11)
A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids. (1989) (11)
Ethical Issues in Including Pediatric Cancer Patients in Drug Development Trials (2002) (11)
MotherNature: establishing a Canadian research network for natural health products (NHPs) during pregnancy and lactation. (2008) (11)
Herbal medicine use in pregnancy: a new frontier in clinical teratology. (2003) (11)
Topical corticosteroid use during pregnancy. (2012) (11)
Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider (2018) (11)
Urine fingerprinting: detection of sample tampering in an opiate dependency program. (1999) (11)
Is lack of morning sickness teratogenic? A prospective controlled study. (2004) (11)
The effectiveness of Proctofoam-HC for treatment of hemorrhoids in late pregnancy. (2009) (11)
Drinking alcohol while breastfeeding (2002) (11)
The transfer, of cocaethylene across the human term placental cotyledon perfused in vitro. (1997) (11)
Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List (2018) (11)
Kinetics of intravenous phenytoin in children. (1984) (11)
Cumulative data on pregnancy outcomes after exposure to fingolimod and in comparison with the general population (2013) (11)
A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose (2015) (11)
Motherisk rounds. Warfarin embryopathy following low-dose maternal exposure. (2005) (11)
Timolol Concentrations in Breast Milk of a Woman Treated for Glaucoma: Calculation of Neonatal Exposure (2008) (11)
Prenatal Adverse Effects of Various Drugs and Chemicals (1988) (11)
Exposure to rufinamide and risks of CNS adverse events in drug‐resistant epilepsy: a meta‐analysis of randomized, placebo‐controlled trials (2014) (11)
The association between maternal cigarette smoking and psychiatric diseases or criminal outcome in the offspring: a precautionary note about the assumption of causation. (1999) (11)
Intranasal midazolam for febrile seizures. A step forward in treating a common and distressing condition. (2000) (11)
The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study (2017) (11)
Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services. (2008) (11)
Update on motherisk updates. Seven years of questions and answers. (2002) (11)
Hair as a biomarker of polybrominated diethyl ethers' exposure in infants, children and adults. (2012) (11)
Clinical relevance of therapeutic drug monitoring of digoxin and gentamicin in the saliva of children. (1998) (11)
Adverse placental effect of formic acid on hCG secretion is mitigated by folic acid. (2013) (11)
Prenatal supplementation with multivitamins and the incidence of pediatric cancers: Clinical and methodological considerations (2008) (11)
In Vitro Testing for Hypersensitivity‐Mediated Adverse Drug Reactions: Challenges and Future Directions (2011) (11)
A new indication for therapeutic drug monitoring in the neonate. (2006) (11)
Pharmacologic treatment of hyperthyroidism during lactation. (2009) (11)
Continuing drug therapy while breastfeeding. Part 2. Common misconceptions of physicians. (1999) (11)
Safety of the newer class of opioid antagonists in pregnancy. (2014) (11)
In vitro analysis of human transplacental transport of desmopressin. (2004) (11)
How High Can We Go With Phenytoin? (2002) (10)
Safety of vaginal delivery in very low birthweight vertex singletons: a meta-analysis (2016) (10)
Screening and referral to identify children at risk for FASD: Search for new methods 2006-2013. (2014) (10)
Managing skin toxicities related to panitumumab. (2014) (10)
Urinary iron excretion depends on the mode of administration of the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one in patients with homozygous β‐thalassemia (1994) (10)
[Infectious complications with herpes virus after ritual Jewish circumcision: a historical and cultural analysis]. (2005) (10)
Generalized Seizures Following Topical Lidocaine Administration During Circumcision (2007) (10)
Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps. (2006) (10)
Bioavailability of nifedipine: a comparison between two preparations. (1984) (10)
Misinterpretation of iron-binding capacity in the presence of deferoxamine. (1991) (10)
Sex dependent pharmacokinetics and bioequivalence--time for a change. (2013) (10)
Continuous infusions of lumbar epidural fentanyl and intravenous fentanyl for post-thoracotomy pain relief. I: Analgesic and pharmacokinetic effects. (1990) (10)
The Predictive Value of the In Vitro Platelet Toxicity Assay (iPTA) for the Diagnosis of Hypersensitivity Reactions to Sulfonamides (2013) (10)
Screening for depressive symptoms. (2011) (10)
Interactions of drugs with the developing kidney. (1995) (10)
The safety of amoxicillin and clavulanic acid use during the first trimester of pregnancy (2019) (10)
Falling between the cracks: a case of amiodarone toxicity (2011) (10)
Optimizing Treatment for Children in the Developing World (2015) (10)
Longitudinal Study of Depression, Anxiety, Irritability, and Stress in Pregnancy Following Evidence-Based Counseling on the Use of Antidepressants (2007) (10)
The fetal safety of cetirizine: An observational cohort study and meta-analysis (2014) (10)
Digoxin-amiodarone interaction: in vivo and in vitro studies in rats. (1983) (10)
Separating Wheat from Chaff: Joining Biomedical Knowledge and Patient Data for Repurposing Medications (2019) (10)
The use of antidepressants in pregnancy: focus on maternal risks. (2015) (10)
Multivitamin supplements for pregnant women. New insights. (2004) (10)
Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn: an update. (2010) (10)
Evaluation of brompheniramine safety in pregnancy. (1993) (10)
The opioid dependent mother and newborn- an update. The 6th Annual Ivey Symposium. (2012) (10)
Essay for the 2011 CIHR/CMAJ award: Motherisk — caring for mothers, protecting the unborn (2012) (10)
Endogenous digoxin-like substance(s) associated with uneventful and high-risk pregnancies. (1988) (10)
Misdiagnosis of a mexiletine overdose because of a nonspecific result of urinary toxicologic screening. (2000) (10)
Emerging biomarkers of intrauterine neonatal and pediatric exposures to xenobiotics. (2012) (10)
The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study. (2019) (10)
Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care. (1999) (9)
Finasteride. Does it affect spermatogenesis and pregnancy? (2001) (9)
N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort (2014) (9)
Prevalence of Ethanol Use Among Pregnant Women in Southwestern Uganda (2016) (9)
Donated breast milk stored in banks versus breast milk purchased online. (2015) (9)
The effect of acyclovir on the tubular secretion of creatinine in vitro (2010) (9)
The Folic Acid Rescue Strategy: High-Dose Folic Acid Supplementation in Early Pregnancy. (2015) (9)
The effect of N-acetylcysteine on the antitumor activity of ifosfamide. (2011) (9)
PHARMACOKINETIC INTERACTION BETWEEN NIFEDIPINE AND PROPRANOLOL (1988) (9)
Counseling pregnant women treated with paroxetine. Concern about cardiac malformations. (2006) (9)
Cancer in Pregnancy: Maternal and Fetal Risks: Maternal and fetal outcome following Hodgkin's disease in pregnancy (1996) (9)
Is ondansetron safe for use during pregnancy (2012) (9)
Comparison of methods for prediction of nephrotoxicity during development. (1992) (9)
The use of cannabis for Hyperemesis Gravidarum (HG) (2020) (9)
Predictive Value of the Lymphocyte Toxicity Assay in the Diagnosis of Drug Hypersensitivity Syndrome (2010) (9)
Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome. (2010) (9)
Retinoids in Clinical Practice: The Risk-benefit Ratio (1992) (9)
Hot yoga and pregnancy: fitness and hyperthermia. (2014) (9)
Longitudinal change in the treatment of nausea and vomiting of pregnancy in Ontario. (2000) (9)
Theophylline pharmacokinetics in adolescent females following coadministration of oral contraceptives. (1985) (9)
Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function. (1993) (9)
A prospective study of nausea and vomiting in pregnancy STATE OF THE ART 2000 (2000) (9)
Cocaine in pregnancy: analysis of fetal risk. (1992) (9)
Re: Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer [corrected]. (2008) (9)
Comparing the Pharmacokinetics of Doxylamine/Pyridoxine Delayed‐Release Combination in Nonpregnant Women of Reproductive Age and Women in the First Trimester of Pregnancy (2013) (9)
Dosage requirements for periconceptional folic acid supplementation: accounting for BMI and lean body weight. (2012) (9)
From Bench to Bedside: Utilization of an In Vitro Model to Predict Potential Drug‐Drug Interactions in the Kidney: The Digoxin‐Mifepristone Example (2003) (9)
Risk of major congenital malformations following first‐trimester exposure to vaginal azoles used for treating vulvovaginal candidiasis: a population‐based retrospective cohort study (2018) (9)
Maternal Use of Ginseng and Neonatal Androgenization-Reply (1991) (9)
Fetal Pharmacotherapy (2012) (9)
Scary Science: Ondansetron Safety in Pregnancy-Two Opposing Results From the Same Danish Registry. (2014) (9)
Interpretation of elevated postmortem serum concentrations of digoxin in infants and children. (1989) (9)
Proactive approach for the evaluation of fetal safety in chemical industries. (1999) (9)
Cocaine inhibits hCG secretion by the human term placental cotyledon perfused in vitro. (1995) (9)
HYPOTHETICAL FRAMEWORK : FASD AND CRIMINALITY – CAUSATION OR ASSOCIATION ? THE LIMITS OF EVIDENCE-BASED KNOWLEDGE (2004) (9)
Ethics of Research in Pediatric Emergency Medicine (2015) (9)
Anorectal symptom management in pregnancy: development of a severity scale. (2011) (9)
The Antiemetic Effect of Cetirizine during Pregnancy (2000) (9)
The Principle of Equipoise in Pediatric Drug Trials (2015) (9)
Acid-suppressing drugs during pregnancy. (1997) (9)
Adverse events in breastfed infants exposed to antihistamines in maternal milk (1995) (9)
NSAIDs and spontaneous abortions - true effect or an indication bias? (2015) (9)
Biotransformation of carcinogenic arylamines and arylamides by human placenta. (1994) (9)
The state of pediatric clinical pharmacology: An international survey of training programs (1989) (9)
Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes. (2001) (9)
Examining the health and drug exposures among Canadian children residing in drug-producing homes. (2011) (9)
No one asked the baby -- an ethical issue in placebo-controlled trials in pregnant smokers. (2005) (9)
Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin. (1998) (9)
Effects of selective serotonin reuptake inhibitors on sperm and male fertility (2015) (8)
Utility of Antiepileptic Drug Monitoring in the Pediatric Emergency Department (2003) (8)
New postmarketing surveillance data supports a lack of association between quinolone use in pregnancy and fetal and neonatal complications (1995) (8)
The generalizability of trial data; a comparison of beta-blocker trial participants with a prospective cohort of women taking beta-blockers in pregnancy. (2001) (8)
Congenital cytomegalovirus infection. Is there a breakthrough? (2001) (8)
SSRIs in Pregnancy –Are they safe? (2002) (8)
Zopiclone use during pregnancy. (2000) (8)
Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations. (2007) (8)
Prescribing antidepressants to pregnant women: what is a family physician to do? (2007) (8)
Reversible hypertrophic osteoarthropathy associated with cyanotic congenital heart disease. (1982) (8)
Age dependent safety and efficacy of colchicine treatment for familial mediterranean fever in children. (2019) (8)
Clinical toxicology of the neonate. (1992) (8)
Pregnancy‐induced changes in the long‐term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: A randomized clinical trial (2015) (8)
Drug Exposure in Pregnancy and Heart Defects (2011) (8)
Topical skin anesthesia. (1989) (8)
Folate status of women in Toronto: Implications of folate fortification and supplementation (2015) (8)
Are statins teratogenic in humans? Addressing the safety of statins in light of potential benefits during pregnancy (2013) (8)
Vaginal antimycotics and the risk for spontaneous abortions (2018) (8)
Rationale for treating pregnant smokers with nicotine patches. (1998) (8)
Use of Cannabis in Fetal Alcohol Spectrum Disorder. (2020) (8)
Maternal-fetal toxicology (2013) (8)
Amphotericin-Induced Heart-Rate Decrease in Children (1995) (8)
Bentiromide Test (bt-Paba) for Diagnosing Pancreatic Insufficiency in Young-Children (1987) (8)
THE CORRELATION BETWEEN FENTANYL PHARMACOKINETICS AND PHARMACODYNAMICS IN PRETERM INFANTS DURING PDA LIGATION (1984) (8)
Controversies in antenatal corticosteroid treatment. (2000) (8)
Assessment of hair cortisol as a potential biomarker for possible adrenal suppression due to inhaled corticosteroid use in children with asthma: A retrospective observational study. (2018) (8)
Subtherapeutic risperidone serum concentrations in an adolescent during hemodialysis: a pharmacological puzzle. (2005) (8)
The communication of pharmacogenetic research results: participants weigh in on their informational needs in a pilot study. (2011) (8)
Pharmaceutical agents and pregnancy in urology practice. (2007) (8)
Developmental renal tubular toxicity: a hypothetical framework and experimental approaches☆ (2001) (8)
Digoxin‐carvedilol interactions in children (2003) (8)
Universal versus Selective Iron Supplementation for Infants and the Risk of Unintentional Poisoning in Young Children: A Comparative Study of Two Populations (2007) (8)
The role of cellular phone usage by parents in the increase in ASD occurrence: A hypothetical framework. (2018) (8)
Norcocaine in human hair as a biomarker of heavy cocaine use in a high risk population. (2014) (8)
Hypothyroidism during pregnancy. (2004) (8)
Hypothetical framework for enhanced renal tubular secretion of drugs in cystic fibrosis. (1998) (8)
Taking antidepressants during late pregnancy. How should we advise women? (2005) (8)
Cancer chemotherapy during pregnancy. Consortium of cancer in pregnancy evidence. (2001) (8)
Bias against the null hypothesis: scaring pregnant women about drugs in pregnancy. (2014) (8)
Essence of preconception counseling and care (2011) (8)
Interpretation of excessive levels of inhaled tobramycin. (1989) (8)
Fetal Safety of Methylphenidate-A Scoping Review and Meta Analysis. (2020) (8)
ARE MOTHERS WHO DRINK HEAVILY IN PREGNANCY VICTIMS OF FAS (2003) (8)
Pharmacokinetic analysis of cloxacillin loss in children undergoing major surgery with massive bleeding (1990) (8)
Associations of sociodemographic and clinical factors with perinatal depression among Israeli women: a cross-sectional study (2019) (8)
Effect of hypothermia on the pharmacokinetics of ethanol in piglets. (1988) (8)
Studying the antiemetic effect of vitamin B6 for morning sickness: Pyridoxine and pyridoxal are prodrugs (2014) (8)
Motherisk alert: Folic acid fortification of flour--three years later. (2001) (7)
Penile absorption of EMLA cream in piglets: implications for use of EMLA in neonatal circumcision. (1995) (7)
Neurodevelopment of Children After Maternal Hospitalization for Nausea and Vomiting of Pregnancy [252] (2015) (7)
Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation. (2018) (7)
VALIDATION OF THE FACIAL PHOTOGRAPHIC METHOD IN FETAL ALCOHOL SPECTRUM DISORDER SCREENING AND DIAGNOSIS (2006) (7)
Ethical Issues in Pharmacologic Research in Women Undergoing Pregnancy Termination: A Systemic Review and Survey of Researchers (2011) (7)
Cancer in Pregnancy: Maternal and Fetal Risks: Maternal and fetal outcome following breast cancer in pregnancy (1996) (7)
Maternal Codeine is Not Safe for all Breast-Fed Infants (2006) (7)
Detection of stimulant drugs of abuse in maternal and neonatal hair (2007) (7)
31: Preemptive Diclectin therapy for the management of nausea and vomiting of pregnancy and hyperemesis gravidarum (2012) (7)
Is it safe to use inhaled corticosteroids in pregnancy? (2014) (7)
Agreement Between Prospective and Retrospective Reports of Maternal Exposure to Chemicals During Pregnancy (2002) (7)
Comparison of verbal claims for natural health products made by health food stores staff versus pharmacists in Ontario, Canada. (2006) (7)
Improving medicines for children in Canada. Findings of the expert panel on therapeutic products for infants, children and youth. (2014) (7)
Studying the safety of ribavirin in human pregnancy. (1990) (7)
Pregnancy after stem cell transplantation. (2005) (7)
Pharmacogenomic investigation of adverse drug reactions(ADRs): the ADR prioritization tool, APT. (2013) (7)
Fetal pharmacotherapy 4: fetal thyroid disorders. (2014) (7)
Public preferences for counseling regarding antidepressant use during pregnancy: a discrete choice experiment. (2012) (7)
Protecting young children from life-threatening drug toxicity. (2013) (7)
Cancer in Pregnancy: Maternal and Fetal Risks: Review of fetal effects of cancer chemotherapeutic agents (1996) (7)
Forensic Investigation of Methadone Concentrations in Deceased Breastfed Infants (2016) (7)
Cocaine transfer across a cocaine exposed placental cotyledon perfused in vitro. (1995) (7)
Comparative study of the ocular efficacy and safety of diclofenac sodium 0 . 1 % ophthalmic solution with that of ketorolac tromethamine 0 . 5 % ophthalmic solution in patients with acute seasonal allergic conjunctivitis (2009) (7)
Cancer in Pregnancy: Maternal and Fetal Risks: Fetal outcome following in utero exposure to cancer chemotherapy: the Toronto Study (1996) (7)
Eating fish during pregnancy. Risk of exposure to toxic levels of methylmercury. (2002) (7)
To accept or reject? A guide to peer reviewing of medical journal papers. (2012) (7)
MEGA-DOSE VITAMIN C AND E IN PREVENTING FASD: THE DECISION TO TERMINATE THE STUDY PREMATURELY (2007) (7)
Can we use metronidazole during pregnancy and breastfeeding? Putting an end to the controversy. (2000) (7)
Iron bioavailability in prenatal multivitamin supplements with separated and combined iron and calcium. (2004) (7)
How Women Perceive Teratogenic Risk and What They Do about It (1993) (7)
Pharmacotherapy and Pregnancy (2009) (7)
Neonatal hair test for cocaine. Toronto experience. (1997) (7)
Measuring the severity of nausea and vomiting of pregnancy; a 20-year perspective on the use of the pregnancy-unique quantification of emesis (PUQE) (2020) (7)
Perspectives of mothers with substance use problems on father involvement. (2008) (7)
Biological and toxic properties of deferoxamine. (1989) (7)
Prevalence of Ethanol Use Among Pregnant Women in Southwestern Uganda. (2015) (7)
Early treatment of acute myocardial infarction with intravenous streptokinase. A high-risk syndrome. (1987) (7)
The ethics of multiple blood sampling in children for research. (1997) (7)
The Motherisk Alcohol and Substance Use Helpline: 10 years of experience and counting. (2010) (7)
Medical Research in Infants and Children in the Eighties: Analysis of Rejected Protocols (1990) (7)
Drug Compliance by Adolescent and Young Adult Cancer Patients: Challenges for the Physician (2007) (7)
Counseling sexually active teenagers treated with potential human teratogens. (1997) (7)
Does vitamin K prophylaxis prevent bleeding in neonates exposed to enzyme-inducing antiepileptic drugs in utero? (2006) (7)
Can we use anxiolytics during pregnancy without anxiety? (2000) (7)
Handling of digoxin and ouabain by renal tubular cells (LLC-PK1). (1992) (7)
Welcome to cyberspace. (2004) (7)
Fentanyl-oxygen versus fentanyl-N2O/ oxygen anaesthesia in children undergoing cardiac surgery (1986) (6)
Association Between Serum Magnesium Levels and Alzheimer’s Disease or Mixed Dementia Patients: A Population-Based Retrospective Controlled Study (2020) (6)
Digoxin‐Verapamil Interaction: In Vitro Studies in Rat Tissue (1983) (6)
Pregnancy outcome in women receiving atypical antipsychotic drugs: A prospective, multicentre, controlled study (2003) (6)
Teratogen information service for pharmacists: a pilot study. (2011) (6)
Once-daily versus twice-daily dosing of digoxin in the pediatric age group. (1990) (6)
Changing trends in the treatment of asthma in a tertiary Canadian pediatric hospital. (1993) (6)
Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever. (2019) (6)
Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children (2014) (6)
Effect of counseling on maternal reporting of adverse effects in nursing infants exposed to antibiotics through breast milk. (1995) (6)
Enantioselective metabolism of ifosfamide by the kidney. (2006) (6)
Comparison of the Digitalis Receptor in Erythrocytes from Preterm Infants and Adults (1988) (6)
Glucosamine use in pregnancy: an evaluation of pregnancy outcome. (2007) (6)
Filing a complaint (1999) (6)
Exposure to calcium channel blockers in human pregnancy: a prospective, controlled, multicentre cohort study (1994) (6)
A Proposed Framework to Address Needs of Clinical Data for Informed Medication Use in Pregnancy (2014) (6)
Bias Against the Null Hypothesis in Retrospective Registries of Gestational Drug Exposure. (2016) (6)
Interpretation of combined hair fatty acid ethyl esters, cocaine and cocaethylene. (2011) (6)
Bacterial vaginosis during pregnancy. Should we screen for and treat it? (2002) (6)
Pediatric clinical use of the ketoconazole/cyclosporin interaction (1994) (6)
Kinetics of CSF Phenytoin in Children (1983) (6)
The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate (2019) (6)
Foetal outcomes after exposure to albendazole in early pregnancy (2017) (6)
Prevalence of Fetal Alcohol Exposure by Analysis of Meconium Fatty Acid Ethyl Esters; A National Canadian Study (2019) (6)
The fatty acid ethyl esters (FAEE) hair test: emerging technology for the diagnosis of fetal alcohol spectrum disorders (FASD) (2009) (6)
Hypothetical framework for a relationship between maternal thyroid function, nausea and vomiting of pregnancy, and congenital heart disease. (2001) (6)
TO LABEL OR NOT TO LABEL: THE PROS AND CONS OF ALCOHOL WARNING LABELS IN PREGNANCY (2004) (6)
Averting the foul taste of pediatric medicines improves adherence and can be lifesaving – Pheburane® (sodium phenylbutyrate) (2016) (6)
Hair Nicotine and Cotinine in Women and Newborn Infants-Reply (1994) (6)
Systemic Bioavailability and Pharmacokinetics of the Doxylamine–Pyridoxine Delayed-Release Combination (Diclectin) (2011) (6)
Is post exposure prevention of teratogenic damage possible: Studies on diabetes, valproic acid, alcohol and anti folates in pregnancy: Animal studies with reflection to human. (2018) (6)
Herpes zoster during pregnancy. (2011) (6)
40: Transplacental transfer of glyburide: is it clinically significant? (2012) (6)
What were they drinking? A preliminary study of alcohol metabolites in Andean mummy hair (2005) (6)
Rational Pharmacotherapy for Childhood Sleep Disturbances: Characteristics of an Ideal Hypnotic (2002) (6)
Screening for fetal alcohol spectrum disorder. (2005) (6)
Effects of drugs on the fetus. (2005) (6)
Suboptimal Pharmacotherapy for Depression in Pregnancy (2003) (6)
Advances in the Determination of Alcohol and Other Drug Consumption during Pregnancy: A Study of 900 Births in Montevideo, Uruguay (2007) (6)
Nicotine-replacement therapy in pregnancy-the end of the road? (2012) (6)
Dose-Dependent Teratology in Humans: Clinical Implications for Prevention (2018) (6)
Transplacental pharmacokinetics of cocaine and benzoylecgonine in plasma and hair of rhesus monkeys. (1998) (6)
Prediction of atrial and ventricular fibrillation complicating myocardial infarction from admission data: A Prospective Study (1987) (6)
Safety of Mebendazole Use During Lactation: A Case Series Report (2016) (6)
Paternal alcohol exposure and Turner syndrome. (2002) (6)
First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete. (2010) (6)
Disposition of oral methotrexate in children with acute lymphoblastic leukemia and its relation to 6-mercaptopurine pharmacokinetics. (2006) (6)
Treating the mother, protecting the unborn: the motherisk approach. (2013) (6)
Hypertension: ACE inhibitor use in pregnancy—setting the record straight (2012) (6)
NEURAL TUBE DEFECT RATES FOLLOWING IN UTERO EXPOSURE TO VALPROIC ACID (2005) (6)
Alcohol consumption in early pregnancy. How much will harm a fetus? (1996) (6)
Is periconceptional opioid use safe? (2015) (6)
Mycophenolate mofetil: emerging as a potential human teratogen. (2008) (6)
Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter. (2009) (6)
Preschoolers' hair cortisol levels are linked to parental income. (2014) (6)
Daclizumab therapy for children with corticosteroid‐resistant acute graft‐vs.‐host disease (2009) (6)
Exposure to electromagnetic fields during pregnancy. (2003) (6)
Folic acid and colorectal cancer: unwarranted fears. (2011) (6)
Knowledge and practice by Canadian Family physicians regarding periconceptional folic acid supplementation for the prevention of neural tube defects (1996) (6)
Multinational Gilenya (TM) (Fingolimod) Pregnancy Exposure Registry: Preliminary Results (2013) (6)
Sequestration of fentanyl by the cardiopulmonary bypass (CPBP) (2004) (6)
Antidepressants and breast-feeding. (1997) (6)
Parity and the use of folic acid supplementation during pregnancy (2019) (6)
In utero exposure to therapeutic radiation for Hodgkin lymphoma. (2009) (6)
Cocaethylene as a biomarker to predict heavy alcohol exposure among cocaine users. (2012) (6)
The transfer of glyburide into breast milk (2004) (6)
Drug-induced nephrotoxicity in children: pharmacologically based prevention of long-term impairment. (2007) (6)
Characteristics of the digoxin-quinidine and digoxin-verapamil interactions in the rat kidney. (1984) (6)
FAEEs in meconium as biomarkers of maternal drinking habit during pregnancy. (2009) (6)
H1N1 influenza in pregnancy: risks, vaccines, and antivirals. (2009) (6)
Evaluating a filter device used for intermittent intravenous drug delivery to newborn infants. (1985) (6)
Ethical boundaries of medical research in infants and children in the 80s: analysis of rejected protocols and a new solution for drug studies. (1990) (5)
BREAKING THE CYCLE - A UNIQUE MODEL FOR FASD RESEARCH (2004) (5)
Pharmacokinetic interaction between zidovudine and trimethoprim/sulphamethoxazole in HIV-1 infected children. (2000) (5)
Toxicokinetics of Mercury Elimination by Succimer in Twin Toddlers (2005) (5)
Polyunsaturated fatty acids and fetal brain development. (2015) (5)
Sex differences in the pharmacokinetics and bioequivalence of the delayed‐release combination of doxylamine succinate‐pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy (2013) (5)
Toxic ingestion of 6-mercaptopurine by young siblings of pediatric oncology patients. (2004) (5)
Tumour necrosis factor alpha and use of infliximab. Safety during pregnancy. (2005) (5)
Functional asplenia in immunoblastic lymphoma. (1982) (5)
The first description of fetal alcohol syndrome by French pediatrician Paul Lemoine. (2012) (5)
Methodological issues in studying the effect of the new oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) on absorption of iron. (1990) (5)
Paediatric clinical pharmacology and the health of the world's children. (1990) (5)
Authors' Response: More research on paracetamol is required. (2014) (5)
The Global Alliance for Pediatric Pharmacology (2009) (5)
Folic acid to prevent neural tube defects: another solution (2016) (5)
Severe extrapiramidal symptoms after nonintentional risperidone exposure in a child: case report and review of the literature. (2011) (5)
Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programs (2009) (5)
Unusual reactions to 5‐HT3 receptor antagonists in a child with rhabdomyosarcoma (2009) (5)
Fluoxetine Distribution in Human Milk (1996) (5)
Is it appropriate to study the pharmacokinetics of drugs aimed at pregnant women in men? (2010) (5)
Deferiprone-Induced Agranulocytosis (1997) (5)
Taking drugs during pregnancy. How safe are the unsafe? (2001) (5)
Pharmacological Treatment for Pregnant Women who Smoke Cigarettes (2003) (5)
Clinical Data for Informed Medication Use in Pregnancy (2014) (5)
Periconception folic acid supplementation. Knowledge and practice of Canadian family physicians. (1997) (5)
Prostaglandin-induced antral hyperplasia in neonates: clinical experience and dose-response characteristics. (1993) (5)
Drugs in pregnancy: acknowledging challenges--finding solutions. (2007) (5)
Identification of repurposable drugs with beneficial effects on glucose control in type 2 diabetes using machine learning (2019) (5)
Toxicology and teratology of the active ingredients of professional therapy MuscleCare products during pregnancy and lactation: a systematic review (2015) (5)
Sea water desalination: A newly discovered cause of iodine deficiency (2018) (5)
Estimation of fetal risk from aerosolized pentamidine in pregnant healthcare workers. (1994) (5)
Information and consultation for drug, chemical and radiation exposure in pregnancy: what bothers women most commonly? (1987) (5)
Is air travel in pregnancy safe? (2008) (5)
RETRACTED ARTICLE:Fetal safety of medications used in treating infertility (2020) (5)
Weight-depression association in a high-risk maternal population (2012) (5)
Meconium testing for fatty acid ethyl esters: a 2011 status report. (2011) (5)
Preconception counseling: rational, practice and challenges. (2011) (5)
Nonsteroidal anti-inflammatory drugs for rheumatoid arthritis during pregnancy. (2005) (5)
The eutectic mixture of local anesthetics: changing the risk-benefit ratio in pediatric research. (1992) (5)
Unsuspected prenatal opioid exposure: long-term detection by alternative matrices. (2010) (5)
Antimicrobial Therapy in Infants and Children (1988) (5)
Neonatal and pediatric clinical pharmacology. (2012) (5)
Use of a Eutectic Mixture of Local Anesthetics for Prolonged Subcutaneous Drug Administration (1995) (5)
Managing exposure to chickenpox during pregnancy. New program. (1998) (5)
DIAGNOSIS AND MANAGEMENT OF NAUSEA AND VOMITING IN PREGNANCY (2006) (5)
Confirmation of Cocaine Use During Pregnancy: A Critical Review (2001) (5)
Pregnancy outcome following fetal exposure to tiaprofenic acid in the first trimester. (1993) (5)
Fentanyl-oxygen versus fentanyl-N2O/oxygen anaesthesia in children undergoing cardiac surgery. (1986) (5)
Sclerodermalike esophageal disease in children of mothers with silicone breast implants. (1994) (4)
Cancer in Pregnancy and Lactation: The Motherisk Guide (2011) (4)
Comment: Possible Mechanism of Digoxin–Itraconazole Interaction (1997) (4)
Prospective study of hydroxyzine use in pregnancy (1993) (4)
A child exposed to primidone not prescribed for her. (2013) (4)
How to ensure fetal safety when mothers use isotretinoin (Accutane). (1997) (4)
507 Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children (1997) (4)
Metformin use during the fi rst trimester of pregnancy (2006) (4)
The use of teratogen information services for research: assessment of reliability of data entry. (1994) (4)
Breaking the cycle (BTC)- 20 years of breaking records in managing addicted mothers and their young children. (2014) (4)
Oral cavity swabbing for diagnosis of group a Streptococcus: a prospective study (2020) (4)
Dermatologic drugs in pregnancy. (1991) (4)
Misrepresentation and miscommunication of teratogenic risk of drugs; analysis of three highly publicized international cases. (2001) (4)
Alcohol content in declared non-to low alcoholic beverages: implications to pregnancy. (2010) (4)
Effectiveness of doxylamine-pyridoxine for morning sickness. (2016) (4)
Training Clinicians in Pediatric Pharmacology-Toxicology (2009) (4)
Updated Guidelines for the Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum (2013) (4)
A patient with seizures and a positive drug screen: three wrongs don't make a right. (2003) (4)
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain. (2011) (4)
Effect of infusion rates on toxicity of amphotericin B (1992) (4)
The global alliance for pediatric pharmacology: the future is here and now. (2009) (4)
Adopted children from the former Soviet Union: are they at risk of fetal alcohol spectrum disorder? (2013) (4)
Periconceptional use of folic acid to reduce the rates of neural tube defects: is it working? (2000) (4)
Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges (2012) (4)
Selective serotonin reuptake inhibitors and risk for major congenital anomalies. (2011) (4)
When pregnant women are not screened for HIV. (2007) (4)
Erythema infectiosum (Fifth disease) and pregnancy. (1999) (4)
Is it safe to breastfeed while taking methylphenidate? (2015) (4)
Folate Fortification and Survival of Children with Acute Lymphoblastic Leukemia (2011) (4)
ATTENUATING THE EFFECTS OF PRENATAL ALCOHOL EXPOSURE WITH POSTNATAL INTERVENTIONS: CRITICAL REVIEW OF ANIMAL STUDIES AND APPLICATIONS TO CLINICAL RESEARCH (2006) (4)
Investigating the fetal and postnatal effects of paternal alcohol exposure in mouse offspring: a review. (2015) (4)
Is mild-moderate drinking in pregnancy harmless? New experimental evidence to the opposite. (2013) (4)
Agonal elevation in serum digoxin concentrations in infants and children long after cessation of therapy. (1988) (4)
Reliability of maternal reporting in identifying major congenital malformations. (2002) (4)
Tramadol withdrawal in a neonate: only one of the clinical presentations to be anticipated… (2009) (4)
Preconceptional monitoring of mercury levels in hair and blood as a tool for minimizing associated reproductive risks. (2014) (4)
A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee. (2001) (4)
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. (2003) (4)
Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effects (2018) (4)
Alert over sound-alike drugs. (1997) (4)
A831 EPIDURAL VS INTRAVENOUS FENTANYL INFUSIONS IN POSTTHORACOTOMY PATIENTSANALGESIC AND PHARMACOKINETCI EFFECTS (1990) (4)
Pregnancy outcome of women who failed appointments at a teratogen information service clinic. (2002) (4)
73 Burden of Prenatal Exposure to Alcohol: Measurement of Costs (2004) (4)
Medicinal Use of Cannabis in Children and Pregnant Women (2020) (4)
How to increase your funding chances: common pitfalls in medical grant applications. (2005) (4)
Ongoing regional prevalence study of fetal alcohol exposure as determined by Meconium analysis of fatty acid ethyl esters (2005) (4)
Use of the new quinolones during pregnancy. (1996) (4)
Determinants of Adherence to Delayed-Release Doxylamine and Pyridoxine in Patients With Nausea and Vomiting of Pregnancy (2012) (4)
Principles of Drug Prescribing in Infants and Children (1993) (4)
Hypothyroidism in pregnancy. (2007) (4)
Fetal alcohol spectrum disorder and the neurobehavioural screening tool: evaluating the effect of maternal depression. (2014) (4)
The rates of major malformations after gestational exposure to isotretinoin: a systematic review and meta-analysis (2021) (4)
Formation of the Organization of Teratology Information Services (OTIS). The OTIS Executive Committee. (1991) (4)
Folic acid and neural tube defects. Good news at last! (1999) (4)
Does light drinking during pregnancy improve pregnancy outcome? A critical commentary. (2008) (4)
Chapter 25 – Maternal Drug Abuse: Effects on the Fetus and Neonate (2004) (4)
Does breastfeeding have an effect on intelligence? (2000) (4)
Altered PABA pharmacokinetics in cystic fibrosis (1985) (4)
Patterns of Antiemetic Use Among American Women With Nausea and Vomiting of Pregnancy (2014) (4)
Authors' reply (2008) (4)
Fetal alcohol syndrome. Role of the family physician. (1998) (4)
SAFETY OF LIDOCAINE-PRILOCAINE CREAM (EMLA) IN PREMATURE AND FULL-TERM NEONATES. • 465 (1996) (4)
Antidepressant exposure, maternal depression and pregnancy outcome—Results from The Norwegian Mother and Child Cohort Study (2011) (4)
The efficacy of diazepam in the treatment of acute iron overload in rats. (1998) (4)
Safety of metformin use during the first trimester. (2005) (4)
Peace of Mind During Pregnancy (1989) (4)
Objective Assessment of Environmental Tobacco Smoke (ETS) Exposure in Pregnancy and Childhood (2000) (4)
Intestinal obstruction in pregnancy by ondansetron. (2014) (4)
Paediatric clinical pharmacology training programmes in Canada and the UK: a comparison (2007) (4)
Pharmacologic treatment of nausea and vomiting during pregnancy. (1998) (4)
When positive studies of novel therapies are subsequently nullified: cumulative meta-analyses in preeclampsia. (2015) (4)
Exposure to organic solvents. Does it adversely affect pregnancy? (1999) (3)
Antimalarial drugs for rheumatoid disease during pregnancy. (1999) (3)
Pregnant "DES daughters" and their offspring. (2005) (3)
[Intravenous streptokinase in acute myocardial infarction]. (1985) (3)
Congenital rubella syndrome. How can we do better? (1999) (3)
Universal HIV testing in pregnancy. (2000) (3)
CHARACTERISTICS OF THE CALLERS TO THE MOTHERISK ALCOHOL AND SUBSTANCE USE HELPLINE (2005) (3)
Selective serotonin reuptake inhibitor exposure in pregnancy and neonatal adverse events. (2010) (3)
Relationships between exposure to polyhalogenated aromatic hydrocarbons and organochlorine pesticides and the risk for developing type 2 diabetes: a systematic review and a meta-analysis of exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (2012) (3)
Pregnancy outcomes following maternal exposure to statins: A systematic review and meta‐analysis (2022) (3)
Determination of gestational cocaine exposure by hair (1990) (3)
The effects of mannitol diuresis on digoxin and phenobarbital handling by the kidney: implications for tubular reabsorption and secretion of the cardiac glycoside. (1989) (3)
Epileptics refractory to anticonvulsants (1984) (3)
Offie Soldin, PhD, MBA. (2015) (3)
Critical appraisal rounds: a new training model for clinical pharmacologists. (2007) (3)
Clinical Pharmacology and Therapeutic Drug Monitoring in Neonates and Children (1998) (3)
PIH20 COST OF ILLNESS STUDY OF NAUSEA AND VOMITING OF PREGNANCY IN CANADA (2005) (3)
Withdrawn: Hair Analysis for Drug‐Facilitated Crime: The Critical Role of Hair Growth Rate (2019) (3)
PREGNANCY OUTCOME AFTER CYCLOSPORINE THERAPY DURING PREGNANCY: A META-ANALYSIS1 (2001) (3)
CHIPS-Child: Testing the developmental programming hypothesis in the offspring of the CHIPS trial. (2016) (3)
The use of infants in drug research when there is no direct benefit to them: a survey of Canadian health care professionals serving on ethics committees. (1988) (3)
Codeine and breastfeeding – Authors' reply (2008) (3)
Cancer in pregnancy: Motherisk on-line question and answer forum. (2007) (3)
Multinational Gilenya™ (Fingolimod) Pregnancy Exposure Registry: Preliminary Results (P02.134) (2013) (3)
A summer-camp outbreak of beta hemolytic streptococcal tonsillitis. (1985) (3)
Maternal depression and perception of teratogenic risk. (2014) (3)
Pregnancy and isotretinoin therapy (2013) (3)
Calcium blocking agents in pediatric emergency care (1990) (3)
Binding of acetaldehyde to human and Guinea pig placentae in vitro. (2003) (3)
P55 Preventing inappropriate hydroxyurea dosing in children by introducing a child-appropriate preparation (2018) (3)
A quality assurance program for teratogen information services. (1992) (3)
Cancer in Pregnancy: Maternal and Fetal Risks: The Toronto Study Group: methodological notes (1996) (3)
Hypothyroidism in Young Children Following Exposure to Iodinated Contrast Media: An Observational Study and a Review of the Literature. (2018) (3)
Fluconazole exposure during pregnancy. (2015) (3)
Understanding fetal alcohol spectrum disorder--bringing schools and teachers on board. (2011) (3)
Using nitrofurantoin while breastfeeding a newborn. (2014) (3)
Controlled pilot study of rapid amphotericn B infusions (1997) (3)
Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy (2016) (3)
Training clinicians in pediatric pharmacology-toxicology: the Toronto model. (2009) (3)
First-trimester exposure to fluoxetine (prozac). Does it affect pregnancy outcome? (1996) (3)
Contamination of Hair With 3,4-Methylene Dioxymethamphetamine (Ecstasy) in 2 Young Girls from a “Meth Lab” (2008) (3)
Drinking and pregnancy. (1991) (3)
The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24): Configural, Measurement, and Structural Invariance between Nulliparas and Multiparas and across Two Measurement Time Points (2021) (3)
Water by the spoonful (2013) (3)
High risk for neural tube defects; the role of arsenic in drinking water and rice in Asia. (2018) (3)
Child behaviour following low to moderate maternal drinking in pregnancy (2010) (3)
New approaches to topical anesthesia in children (1990) (3)
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment for Postpartum Pain and Avert Infant Adverse Events (2014) (3)
The Safety of Metoclopramide Use in the First Trimester of Pregnancy (2009) (3)
Antiretroviral treatment of maternal HIV infection. (2004) (3)
RETRACTED ARTICLE: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (2019) (3)
Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial (2013) (3)
Effect of Lidocaine-Prilocaine Cream (EMLA®) on Pain of Intramuscular Fluzone® Injection (2018) (3)
Evidence of digoxin metabolism by the kidney. (1987) (3)
Therapeutic failures in epileptic children due to impaired diphenylhydantoin bioavailability. (1982) (3)
Anxiolytic treatment but not anxiety itself causes hyponatremia among anxious patients (2019) (3)
A primer of paediatric toxic syndromes or 'toxidromes' (2007) (3)
Young women taking isotretinoin still conceive. Role of physicians in preventing disaster. (1999) (3)
The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis®) for morning sickness--a new morning for American women. (2013) (3)
Cost effectiveness of teratology counseling - the Motherisk experience. (2014) (3)
Comparison of acceptance of clinical versus basic studies on drugs and therapeutics in infants and children. (1993) (3)
Health Risk of the Walpole Island First Nation Community from Exposure to Environmental Contaminants: A Community-based Participatory Research Partnership (2010) (3)
Pregnancy outcomes following first trimester exposure to topical retinoids: A systematic review and meta-analysis (2015) (3)
How long should someone wait after CMV infection to start pregnancy? (1998) (3)
Does high-dose gestational folic acid increase the risk for autism? The birth order hypothesis. (2019) (3)
Varicella virus vaccine before pregnancy. Important breakthrough in protecting fetuses. (2000) (3)
Appraisal of drug therapy for nausea and vomiting of pregnancy: I. The placebo effect - methodological and practical considerations. (2000) (3)
Intranasal midazolam for febrile seizures (2000) (3)
Cardiovascular effects of cimetidine. (1983) (3)
Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study. (2009) (3)
Annotations and Reflections (2015) (3)
Fetal pharmacotherapy 1: prenatal glucocorticoids. (2013) (3)
Exposure to alcohol-containing medications during pregnancy. (2006) (2)
Medicinal Use of Cannabis in Children and Pregnant Women. (2019) (2)
Studying the safety of ribavirin in human pregnancy (1990) (2)
Hair cortisol concentrations predict change in girls’ depressive symptoms (2020) (2)
Cardiac birth defects induced by maternal medications (2020) (2)
Multinational Gilenya (Fingolimod) Pregnancy Exposure Registry in Multiple Sclerosis: Study Design (P06.189) (2012) (2)
The Transfer Of Dabigatran and Rivaroxaban Across a Dually Perfused Isolated Human Placental Cotyledon – Implications For Therapy In Pregnancy (2013) (2)
Patient-based research in a tertiary pediatric centre: a pilot study of markers of scientific activity and productivity. (1997) (2)
Bias in Maternal Reports of Smoking During Pregnancy Associated With Fetal Distress (2001) (2)
Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants. (2000) (2)
Book Review The Placebo Effect: An interdisciplinary exploration Edited by Anne Harrington. 260 pp. Cambridge, Mass., Harvard University Press, 1997. $39.95. 0-674-66984-3 (1997) (2)
Is topical tretinoin safe during the first trimester? (1998) (2)
The Effects of Cyclosporine Therapy on Pregnancy Outcome in Organ Transplanted Women: A Meta-Analytical Review (1999) (2)
Use of ciprofloxacin during breastfeeding. (2015) (2)
Therapeutic Drug Monitoring of Retinoids (1992) (2)
Retrograde Ejaculation—a Commonly Unspoken Aspect of Prostatectomy for Benign Prostatic Hypertrophy (2020) (2)
BNF for Children 2006 (2006) (2)
Water desalination, serum magnesium and dementia: a population-based study. (2020) (2)
Pregnancy Outcome Following Gestational Exposure to Organic Solvents (2017) (2)
Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. (1999) (2)
Hypospadias induced by medications and environmental exposures- A scoping review. (2021) (2)
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review (2020) (2)
Hyperosmolar metabolic acidosis in burn patients exposed to glycol based topical antimicrobials-A systematic review. (2017) (2)
Optimizing periconceptional folic acid supplementation: Steady‐state folate pharmacokinetics in pregnancy (LB416) (2014) (2)
NEONATAL CIRCUMCISION AND PAIN RESPONSE DURING ROUTINE 4 TO 6 MONTH VACCINATION. • 1070 (1997) (2)
Antenatal visualization of malformations associated with drugs and chemicals (1993) (2)
Cerebrospinal Fluid Pharmacokinetics of Tobramycin, Ceftazidime, Phenobarbitone and Phenytoin in a Child (1985) (2)
Effects of Prenatal Exposure to Prednisone: a Prospective Study.† 348 (1997) (2)
Sex Differences in Pharmacokinetics of Doxylamine–Pyridoxine Combination: Implications for Pregnancy (2014) (2)
Dextromethorphan. Extrapolation of findings from reproductive studies in animals to humans. (1999) (2)
The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults (2021) (2)
Personalized Medicine-Disregarding the Obvious: Analysis of Trends Among Articles Published on "Personalized Medicine". (2015) (2)
Constrictive pericarditis following coronary-artery bypass grafting in a patient with chronic asymptomatic pericardial disease. (1983) (2)
Do silicone breast implants affect breastfeeding? (1998) (2)
Pre-conceptional folic acid supplementation: A possible cause for the increasing rates of ankyloglossia. (2019) (2)
Hypothermia, alkalosis, and barbiturate clearance. (1983) (2)
Metabolic Diseases: Foundations of Clinical Management, Genetics and Pathology—Reply (2001) (2)
Cancer in Pregnancy: Maternal and Fetal Risks: Pregnancy and ovarian cancer (1996) (2)
Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children. (1984) (2)
Chloroquine for Covid 19: introducing drug repurposing to medical students (2020) (2)
Diclectin for morning sickness: Long-term neurodevelopment. (2011) (2)
Maternal cocaine use and risk of sudden infant death. (1989) (2)
Gestational Exposure to Natalizumab and Pregnancy Outcomes_Results From a Prospective Cohort with Relapsing Remitting Multiple Sclerosis (P4.156) (2014) (2)
Workplace Standards for Exposure to Toxicants During Pregnancy (2008) (2)
Quantifying fetal alcohol exposure by meconium fatty acid ethyl esters (FAEE); association with adverse fetal outcomes and population estimates of fetal alcohol exposure (2019) (2)
Pharmacokinetics in Pregnancy (2012) (2)
Neurodevelopment in children exposed in utero to cyclosporine and azathioprine following maternal renal transplant: preliminary results (2004) (2)
Can pregnant patients safely take nitrofurantoin? (1996) (2)
Smoking habits, nicotine use, and congenital malformations. Authors' reply (2006) (2)
Salicylates in Kawasaki disease--a review of clinical pharmacokinetics and efficacy. (1987) (2)
MATERNAL USE OF GINSENG AND NEONATAL ANDROGENIZATION. AUTHOR'S REPLY (1991) (2)
Pregnancy and antidepressant counseling. (2004) (2)
BCRP-mediated Glyburide Transport : Effect of the C 421 A / Q 141 K BCRP Single Nucleotide Polymorphism (2010) (2)
Pregnancy outcome following gestational exposure to amiodarone (1994) (2)
Sea water desalination and removal of iodine: effect on thyroid function. (2018) (2)
Preconceptional folate and neural tube defects: time for rethinking. (1993) (2)
Situs Inversus, Encephalocele and Jejunal Atresia Following Exposure to Gemfibrozil in Pregnancy (2002) (2)
Cancer in Pregnancy: Maternal and Fetal Risks: Malignant melanoma and pregnancy (1996) (2)
Is it all right to drink a little during pregnancy? (2004) (2)
Effect of hyperemesis gravidarum on child neurodevelopment (2018) (2)
Treating morning sickness PRN? (2013) (2)
Adverse Effects of Assisted Reproductive Technology and Pregnancy Outcome (2002) (2)
Efficacy of racemic epinephrine in croup. (1983) (2)
Preventing recurrence of severe morning sickness. (2006) (2)
The Pregnancy Unique Quantification of Emesis (PUQE) for morning sickness. (2008) (2)
Inconsistent Reporting of Potential Conflicts of Interest Disclosure. (2019) (2)
Managing hypothyroidism during pregnancy. (2001) (2)
Potential Prevention of Neural Tube Defects by Assessment of Women of Childbearing Age Through Monitoring of Folate (2002) (2)
Cyclosporin-modulated chemotherapy with focal cryo/laser therapy: a new approach to retinoblastoma (1994) (2)
Pharmacogenomics Principles: Introduction to Personalized Medicine (2012) (2)
PIH5 INCIDENCE OF MAJOR MALFORMATIONS IN INFANTS FOLLOWING ANTIDEPRESSANT EXPOSURE IN PREGNANCY: RESULTS OF A LARGE PROSPECTIVE COHORT STUDY (2008) (2)
Oral Contraceptives and Neutropenia: A Population-Based Cohort Study (2019) (2)
Is chronic poisoning with acetaminophen in children a frequent occurrence in Toronto? (2001) (2)
Keeping it safe in the paediatric emergency department - drug errors and ways to prevent them. (2007) (2)
Pulmonary valve stenosis and hemophilia A. Report of three cases and discussion of a possible genetic linkage. (1986) (2)
Problems with maternal antidepressant treatment and neonatal outcomes study. (2007) (2)
Bacterial vaginosis during pregnancy (2002) (2)
Validation of the facial photographic in fetal alcohol spectrum disorder screening and diagnosis. (2014) (2)
Breakthrough in treating gestational diabetes mellitus. (2004) (2)
Understanding Drugs in Children : Pharmacokinetic Maturation (2008) (2)
Digoxin and indomethacin in preterm infants with PDA. (1984) (2)
Reviewers' bias against the null hypothesis: the reproductive hazard of binge drinking. (2010) (2)
Taking antidepressants during late pregnancy (2005) (2)
FATTY ACID ETHYL ESTERS- A NOVEL BIOLOGICAL MARKER FOR HEAVY IN UTERO ETHANOL EXPOSURE (1999) (2)
[THE APPROACH TO NAUSEA AND VOMITING IN PREGNANCY]. (2015) (2)
Pregnancy Outcome of Women Exposed to Pinaverium Due to a Dispensing Error (1999) (2)
Therapeutic drug monitoring in the lactating patient (1995) (2)
Factors associated with medical complications after body art among Israeli adults: a retrospective study (2021) (1)
Effects of age and cardiac shunts on the measured uptake of nitrous oxide in children. (1991) (1)
Biobanking in Israel 2016–17; expressed perceptions versus real life enrollment (2017) (1)
A pharmacokinetic approach to the diagnosis of pediatric Munchausen by proxy (1996) (1)
UNEXPECTED ABNORMALITIES OF FENTANYL (F) DISPOSITION IN CHILDREN UNDERGOING CARDIAC SURGERY (1984) (1)
Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large cohort study (2008) (1)
The Safety of Methimazole and Propylthiouracil in Pregnancy: A Systematic Review (2013) (1)
Taking folic acid during pregnancy. Don't leave it too late. (1997) (1)
PP220—The risk of birth defects following exposure to nitrofurantoin during first trimester (2013) (1)
Digoxin-verapamil interaction--is it mutual? (1983) (1)
Teratogen Information Services: A Novel Opportunity in Clinical Teratology (1994) (1)
Evaluation of Mitral Valve Regurgitation : Implications for Percutaneous Mitral Valve Repair (1)
A Clinician-Researcher Training Program for Family Medicine Residents. (2019) (1)
In utero exposure to polybrominated diphenyl ethers (PBDEs) and the risk of hypospadias; A case-control study (2018) (1)
PEDIATRIC PHARMACOLOGY AND THERAPEUTICS Pharmacokinetics and adverse effects of amphotericin B in infants and children (1988) (1)
American Gastroenterological Association institute medical position statement on the use of gastrointestinal medication in pregnancy. (2007) (1)
What adversely affects the unborn--psychotropic drugs or maternal morbidity? (2015) (1)
Searching for the Fetal Alcohol Behavioral Phenotype (2020) (1)
Hemophilia during pregnancy. (2003) (1)
Child neurodevelopment following exposure to venlafaxine in utero, unexposed siblings as comparison groups: Preliminary results (2007) (1)
Testing women for HIV. (1997) (1)
Drugs in pregnancy: associations, causation, and misperceptions. (2010) (1)
Infection par le virus de l’hépatite E durant la grossesse (2015) (1)
Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy (2014) (1)
Cardiac glycosides. (1987) (1)
The effect of diazepam in the recovery of rabbits from acute acetaminophen intoxication. (1999) (1)
Water by the spoonful: children of addiction. (2013) (1)
Legal methods of furthering urban preservation: proceedings of the Conference of the International Legal Committee of ICOMOS, Papers submitted to the Israel conference, February 2001 (2002) (1)
Medication Use in Pregnancy; Treating the Mother: Protecting the Unborn (2015) (1)
CHARACTERISTICS OF WOMEN USING MARIJUANA IN PREGNANCY AND THEIR REPORTED EFFECTS ON SYMPTOMS OF NAUSEA AND VOMITING OF PREGNANCY: A PROSPECTIVE, CONTROLLED COHORT STUDY (2003) (1)
Food-borne illnesses during pregnancy. (2010) (1)
The Effects of Counseling and Predictors of Pregnancy Outcomes in Women With Hyperemesis Gravidarum [316] (2015) (1)
W452 ALCOHOL USE AND PREGNANCY CONSENSUS GUIDELINES (2012) (1)
Pharmacokinetics of deferoxamine with and without iron load. (1989) (1)
Glyburide for Gestational Diabetes (2007) (1)
Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy (2020) (1)
Prise en charge de l'infection à la varicelle pendant la grossesse. (2016) (1)
Therapeutic approach to hypertension during pregnancy. (1998) (1)
Gestational Exposure to Serotonin Reuptake Inhibitors and Pregnancy Outcome; Exploring the Role of Bias and Confounders (2020) (1)
BREAKING THE CYCLE: REFLECTIONS ON THE FIRST NINE YEARS (2004) (1)
Estimation of Neonatal Exposure After Accidental Ingestion of Lufenuron in a Breastfeeding Mother (2000) (1)
Fetal pharmacotherapy 2: fetal arrhythmia. (2013) (1)
Motherisk Update Guidelines for maternal codeine use during breastfeeding (2009) (1)
The contribution of propafenone metabolites to the digoxin‐propafenone interaction in MDCK renal tubular cells (1996) (1)
P56 Breakthrough in the treatment of nausea and vomiting of pregnancy; the first dual release combination of doxylamine-pyridoxine (2019) (1)
Workplace standards for exposure to toxicants during pregnancy. (2008) (1)
The ten commandments of giving medications to children: the questions you should get answers to by your physician or pharmacist before giving any medication to your child. (2009) (1)
Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model (2021) (1)
Using antidepressants during pregnancy (2005) (1)
Laryngotracheitis and Croup-Reply (1984) (1)
Increasing Folic Acid Supplementation (2007) (1)
Potential Misclassification of a Case of SIDS: Maternal and Neonatal Hair Analysis for Cocaine and Heroin (1993) (1)
Maturation of renal tubular transport of gentamicin. (1984) (1)
The complete guide to everyday risks in pregnancy & breastfeeding : answers to your questions about morning sickness, medications, herbs, diseases, chemical exposures & more (2004) (1)
Use of 5-aminosalicylic acid by breast feeding mothers 332 (1997) (1)
Teratology and Developmental Pharmacology: Why Should Paediatricians Care? (2011) (1)
Cancer in Pregnancy: Maternal and Fetal Risks: Changes in drug disposition during pregnancy and their clinical implications (1996) (1)
Pregnancy outcome of women exposed to azathioprine during pregnancy: A prospective multicenter international study. (2007) (1)
Screening of the Epileptic Patient - Is it worth the trouble? (1989) (1)
ETHICS OF DRUG STUDIES IN NEONATES: HOW MANY SAMPLES SHOULD BE PERMUTED FOR PHARMACO-KINETIC ANALYSIS (1987) (1)
TDM Journal Club: Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis Immunization During Pregnancy (2015) (1)
Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk? (2014) (1)
Vapor Compounds Released from Nicotine-Free Inhalators as a Smoking-Cessation Aid (2019) (1)
Evaluating the success rate of the dual perfusion of the human placenta ex vivo (2014) (1)
Pregnancy Outcome Following Gestational Exposure to Echinacea: A Prospective Controlled Study (2001) (1)
Twenty-five years of counseling family physicians: What have we learned? (2010) (1)
In Reply: Re: Efficacy of Prilocaine-Lidocaine Cream in the Treatment of Premature Ejaculation (1996) (1)
Consuming non-alcoholic beer and other beverages during pregnancy and breastfeeding. (2014) (1)
Elements of Teratology (2016) (1)
Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial. (2015) (1)
The Control of Hypertension In Pregnancy Study (CHIPS) randomized controlled trial – is severe hypertension just an elevated blood pressure? (2016) (1)
Mother-level random effect in the association between PM2.5 and fetal growth: A population-based pregnancy cohort. (2022) (1)
Corrigendum to "Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use" [Forensic Sci Int 189 (2009) 24-27]. (2015) (1)
Assisted reproductive technology is not associated with an increased risk of pediatric cancer (2018) (1)
Exposure to sibutramine during pregnancy. (2007) (1)
Hair as a novel noninvasive method to study the impact of pregnancy on CYP2D6 metabolizing capacity. (2009) (1)
Determinants of Medication Adherence in Nausea and Vomiting of Pregnancy (2018) (1)
Accelerated metabolism of drugs in late pregnancy: Important clinical implications (2004) (1)
Patient–physician–regulator triad (2005) (1)
Neurodevelopment of children assessed after prenatal exposure to polybrominated diethyl ethers from collapse of world trade center. (2013) (1)
Theophylline and diet. (1981) (1)
Pain Indication in Circumcision (2000) (1)
Clinical and laboratory observations Once-daily versus twice-daily dosing of digoxin in the pediatric age group (1989) (1)
Institutionalized Children and the Risk of Fetal Alcohol Spectrum Disorder (FASD); A Primer for Clinicians, Adoption Staff and Parents (2021) (1)
Hair Cortisol Levels Suggest Hpa Axis Downregulation at Age 7 Years in Boys Born Very Preterm (2013) (1)
The fetus as a passive smoker. (1996) (1)
POSSIBLE CONFOUNDERS IN THE REPORTED ASSOCIATION BETWEEN AUTISM SPECTRUM DISORDER (ASD) AND EXPOSURE TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) DURING PREGNANCY (2015) (1)
Tlb : a Reference Setting Package , Update (1)
OC004—Fetal Exposure To Nonsteroidal Antiinflammatory Drugs (Nsaid) And Spontaneous Abortions (2013) (1)
Antihistamines are safe during the first trimester. (1997) (1)
The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides: a case-control study (2014) (1)
Motherisk Update Hyperthyroidism during pregnancy (2009) (1)
Socio-demographic characteristics and their relation to medical service consumption among elderly in Israel during the COVID-19 lockdown in 2020 as compared to the corresponding period in 2019 (2022) (1)
A Practical Approach to Risk-Benefit Estimation in Pediatric Drug Research (2015) (1)
Chickenpox during pregnancy. Small but real risk. (1995) (1)
Opioid toxicity following breastfeeding in infants (2013) (1)
The pharmacokinetics of inhaled N2O in children. (1985) (1)
[Red man syndrome after vancomycin]. (1992) (1)
Cancer in Pregnancy: Maternal and Fetal Risks: Maternal and fetal outcome following invasive cervical cancer in pregnancy (1996) (1)
Pharmacogenomic predictors of neonatal abstinence syndrome: correlation with length of stay. (2015) (1)
Lack of cisplatin-ranitidine kinetic interactions: in vivo study in children, and in vitro study using dog renal brush border membrane vesicles. (1998) (1)
Prevalence of Fetal Alcohol Spectrum Disorder among High-Risk Children and Adolescents in a Correctional Facility. (2019) (1)
Erratum: “A Case–Control Study of Maternal Polybrominated Diphenyl Ether (PBDE) Exposure and Cryptorchidism in Canadian Populations” (2018) (1)
Traditional botanical medicines (2006) (1)
EFFICACY AND SAFETY OF LIDOCAINE-PRILOCAINE CREAM (EMLA) FOR NEONATAL CIRCUMCISION PAIN. † 1071 (1997) (1)
Book Review: Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. Second Edition (1997) (1)
Effects of amitriptyline, gabapentin, and carbamazepine on morphine‐induced respiratory depression in rabbits (2003) (1)
Cases of Mistaken Identity (2018) (1)
The Pleiotropic Effects of Statins : Fact or Fantasy ? (1)
Limitations in enforcement of international conventions: Implications for protection of monuments and sites (2002) (1)
Spontaneous abortion and NSAIDs (2011) (1)
The Use of Antidepressants in Pregnancy: Focus on Maternal Risks (2015) (1)
Training Clinicians in Maternal-Fetal Pharmacology (2009) (1)
Adolescent Dimenhydrinate Abuse: Old Problem Resurgence of an (1997) (1)
CEDIA’s EDDP immunoassay is a cost-effective compliance marker in an opiate dependency program. (2000) (1)
Use of non-aspirin NSAIDs during pregnancy may increase the risk of spontaneous abortion (2012) (1)
Counseling psychiatric patients about drug exposures during pregnancy. (1998) (1)
Sudden-onset tachypnea and confusion in a previously healthy teenager. (2010) (1)
Changes in drug handling during pregnancy: what it might mean for your patients. (2006) (1)
Nicotine replacement therapy during pregnancy. (2001) (1)
Maternal β-Blocker Usage and Breast Feeding in the Neonate (1999) (1)
[MACCABI HEALTHCARE SERVICES - INNOVATION AS A WAY OF LIFE]. (2018) (1)
BeMORE: a novel method for detection of adverse fetal effects induced by drugs. (2011) (1)
Research on maternal and fetal safety after exposure to antidepressants in utero. (2003) (1)
The reproductive effects of beta interferon therapy for multiple sclerosis (2005) (1)
Creating a New Ethical Climate for Drug Research in Children and Pregnant Women (2015) (1)
SSRIs in late pregnancy: the risk of neonatal respiratory distress and seizures (2011) (1)
Predicting phenytoin serum concentrations (1983) (1)
Characteristics Related to Choice of Obstetrician-Gynecologist among Women of Ethiopian Descent in Israel (2020) (1)
"Prozac Baby" - 25 years of motherisk research into SSRIs and alcohol in pregnancy. (2014) (1)
Tuberculosis during pregnancy. (1996) (1)
Renal tubular interactions of digoxin. (1984) (1)
Response to erythropoietin in pediatric patients with chronic kidney disease: insights from an in vitro bioassay (2018) (1)
[QUANTIFYING PATIENTS' DRUG ADHERENCE BY ELECTRONIC RECORDS OF DRUG PURCHASING]. (2018) (1)
Errors in drug administration. (1987) (0)
Developmental Pharmacology of Aminoglycosides and Vancomycin (2018) (0)
Association between oral contraceptives and serious infections: A population‐based cohort study (2021) (0)
12 PHARMACOKINETICS AKD PULMONARY FUNCTION FOLLOWING A TEST DOSE OF I.V. SALBUTAMCL IN VENTILATED INFANTS KITH BROKCHOPULMOBARY DYSPLASIA (EPD) (1986) (0)
Baby boy blue - why is this newborn lethargic? (2010) (0)
[Accidental hypothermia in healthy adults]. (1976) (0)
The Mechanism Underlying Anaphylactoid Reactions to High Dose Cyclosporine a (CSA) Infusions in Children (1996) (0)
Comprar Medication Safety in Pregnancy and Breasfeeding the Evidence Based A-Z Pocket Guide | Gideon Koren | 9780071448277 | Mcgraw-Hill Education (2007) (0)
Cocaine clearance by the human placenta perfused in vitro (1996) (0)
Effect of Infant Age and Position on Pain Response During Vaccination† 642 (1998) (0)
166 URINE FINGERPRINTING - DETECTION OF A RESUBMITTED URINE SAMPLE IN AN OPIATE DEPENDENCY PROGRAM (1997) (0)
Burden of Illness for Neural Tube Defects: Canadian Perspective (2015) (0)
Defective alleles may not have contributed to adverse effects. (2006) (0)
Development of a rapid LC–MS/MS method for hair cortisol determination to assess the HPA axis (2015) (0)
PIH21 LITERATURE REVIEW OF DISCRETE CHOICE EXPERIMENTS TO ASSESS WOMEN'S PREFERENCES AND WILLINGNESS TO PAY FOR MATERNAL HEALTH SERVICES (2008) (0)
Inhaled Corticosteroids and Fetal Growth (2006) (0)
Cocaine use by pregnant women in Toronto. (1996) (0)
Misinterpretation of iron-binding capacity determination in the presence of deferoxamine (1991) (0)
Is the fetus safe when spermicides fail? (1997) (0)
Cellular mechanisms of digoxin transport and toxic interactions in the kidney. (1986) (0)
Poster Walk IV (2015) (0)
Semiquantitative determination of liver specific antigen in the urine or rats with toxic hepatic necrosis. (1979) (0)
Piracetam Does Not Enhance Cognitive Abilities in Moderate to High-Functioning 7 to 13 Year-old Children with Down Syndrome (1999) (0)
Opioids and Birth Defects (2011) (0)
Maternal Thyroid Anomalies and Risk of Autism Spectrum Disorders (2018) (0)
Epomediol Protective Effect on Ethanol Cytotoxicity In Vitro Human Hepatocytes HEP G2 Cell Line (1993) (0)
Dietary isoprenoids inhibit growth and reduce VEGF secretion in human neuroblastoma (2002) (0)
Autism and Exposure to Thimerosal (2007) (0)
Corrigendum to: "Does high-dose gestational folic acid increase the risk for autism? The birth order hypothesis" [Medical Hypotheses 132 (2019) 109350]. (2019) (0)
Dextromethorphan in Pregnancy (2001) (0)
474: INCIDENCE OF ACUTE KIDNEY INJURY IN CRITICALLY ILL CHILDREN (2012) (0)
ON CIRCADIAN VARIATION IN FOLATE PHARMACOKINETICS (2005) (0)
Measuring oral bioavailability of tacrolimus (2014) (0)
Drug Errors (1987) (0)
Oral Session II‐C (OII‐C) (2012) (0)
Usage : 1 copy will be made in Belgium / UCB PHARMA SA for the following use : " (2001) (0)
Quantity as an expression of quality: relationship between serum drug concentrations and quality of life. (2008) (0)
Safety of nitrofurantoin for urinary tract infection during pregnancy (1995) (0)
Anti-retroviral therapy- pregnancy induced pharmacokinetic changes–Systematic review and meta- analysis (2018) (0)
AB1008 AGE DEPENDENT SAFETY AND EFFICACY OF COLCHICINE TREATMENT FOR FAMILIAL MEDITERRANEAN FEVER IN CHILDREN (2019) (0)
The transfer of rivaroxaban across the dually perfused human placenta (2013) (0)
Training clinicians in Maternal-Fetal Pharmacology: closing a conceptual gap. (2009) (0)
Children of Neverland. (1997) (0)
ERRATUM (1996) (0)
Testing for Drugs of Abuse in the Pediatric Population (2020) (0)
The psychiatric patient: a challenge for a TIS service (1994) (0)
Changes in infant response to painful and non-painful procedures during hospitalization in the neonatal intensive care unit (2005) (0)
Neonatal Withdrawal Symptoms (2008) (0)
The Emerging Use of Cannabis in cases of Hyperemesis Gravidarum; A Critical Review (2020) (0)
Fetal Risks of Environmental Chemicals: The Motherisk Approach to the Organic Mercury Fish Consumption Scare (2012) (0)
Mothersisk update: reproductive outcomes after assisted conception. (2013) (0)
The Safety of Dextromethorphan in Pregnancy: Results of a Controlled Study (2001) (0)
Event Monitoring System . Compliance assessed by the Medication (2007) (0)
Length of chronic exposure to particulate matter and adverse birth outcomes: A population-based cohort study (2020) (0)
Problems in Pediatric Drug Therapy, 4th Edition (2003) (0)
Factors Influencing Childrens, Parents, and Nurses Assessment of Childrens' Pain during Port-A-Cath Puncture (1999) (0)
In Reply: Re (1996) (0)
Update on perinatal HIV. (2001) (0)
Clinical Drug Trials in Pregnancy: Challenges and Solutions (2006) (0)
Natural Health Products (NHPs) in Pregnancy and Lactation: A Review of the Landscape and Blueprint for Change (2011) (0)
Evaluating the Effectiveness of Childbirth Preparation Courses on Women’s Self-Efficacy among Ultra-Orthodox Jewish Religious Women in Israel (2021) (0)
Association of Prenatal Exposures of Polybrominated Diphenyl Ethers With Hypospadias-Reply. (2019) (0)
Evaluating Risks of Drugs in Pregnancy From Biology to Risk Perception (2005) (0)
The pharmacokinetics and pharmacodynamics of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one , depend on hemoglobin levels (1994) (0)
Pharmacological Treatment for Pregnant Women who Smoke Cigarettes (2003) (0)
Fertility of children exposed in utero to chemotherapy (2011) (0)
DICLECTIN THERAPY FOR NAUSEA AND VOMITING OF . (2003) (0)
Fetal Safety of Paroxetine (2010) (0)
Celecoxib pharmacokinetics in pediatric cancer patients–The effects of food and pharmacogenetics (2004) (0)
My Own Invention - Telling Tails: Children's Literature Goes to the Hospital (2017) (0)
Obesity, neural tube defects and folic acid—A complex relationship (2021) (0)
Subject Index, Vol. 74, 1985 (2004) (0)
No 274 - Prise en charge de l'infection à la varicelle pendant la grossesse. (2018) (0)
Legal Forms of Sponsorship in Israel (2015) (0)
Safety of Medications During Pregnancy and Breastfeeding (2012) (0)
Correlation of Morphine in Blood Plasma and Saliva in Pediatric Patients. 324 (1997) (0)
[RATES OF MICROCEPHALY AMONG NEONATES IN AIR POLLUTED REGIONS OF HAIFA BAY]. (2018) (0)
Pursuing teratogenic causes of multiple congenital contractures Editorial (1988) (0)
Effects of Hyperbaric Oxygen Therapy on Brain Perfusion, Cognition and Behavior in Fetal Alcohol Spectrum Disorder-A Case Study. (2019) (0)
THE ONTOGENY OF P-GLYCOPROTEIN IN THE DEVELOPING HUMAN BLOOD BRAIN BARRIER: IMPLICATION FOR OPIOID TOXICITY IN NEONATES (2015) (0)
Authors' Reply (2004) (0)
Treatment of Steroid-Resistant Graft-Versus-Host Disease with Monoclonal Antibodies in Children. (2006) (0)
Mother-level random effect in the association between PM2.5 and low birth weight: A population-based pregnancy cohort in Israel (2020) (0)
Examination of gender bias in fatty acid ethyl ester and ethyl glucuronide hair analysis for determination of excessive alcohol use (2013) (0)
Hyperemesis Gravidarum- Is It A Human Teratogen 7 (2018) (0)
[Cold injuries, Part II: Accidental hypothermia]. (1976) (0)
Gentamicin-digoxin interaction in the rat kidney. (1985) (0)
Thoracic spine 11 Lumber spine 720 Pelvis 210 Abdomen 220 Mammography < 10 Abdominal CT 2000 Chest (2008) (0)
ETHICAL CONSIDERATIONS IN PHARMACOKINETIC STUDIES IN NEONATES (1987) (0)
Effect of patient counseling on the incidence of clinical events reported to the motherisk program (1993) (0)
Acute Changes in Renal Function Associated With Deferoxamine Therapy (1990) (0)
Glyburide is Safe for Gestational Diabetes Mellitus (2005) (0)
CorrespondenceResponse to Letter to the Editor by Corinna Weber-Schoendorfer, PhD, MD, and Christof Schaefer, PhD, MD (2008) (0)
Oral Session II‐A (OII‐A) (2008) (0)
The chest radiograph in the diagnosis of atypical nephritis due to infectious mononucleosis. (1984) (0)
Enhancement of digoxin clearance by mannitol diuresis: in vivo studies and their clinical implications. (1988) (0)
Cocaine does not cause placental vasoconstriction (1996) (0)
Monitoring adverse drug reactions in pregnancy and lactation; the motherisk model. (1991) (0)
324: Treatment of steroid-resistant graft-versus-host disease with monoclonal antibodies in children (2007) (0)
The first documented controlled trial in history. (2015) (0)
Secondary prevention in teratology: Can the consequences of exposure to teratogens be alleviated or attenuated by maternal nutrition? (2018) (0)
Solid-phase microextraction for the detection of codeine, morphine and 6-monoacetylmorphine in human hair by gas chromatographyâ€“mass spectrometry (2010) (0)
Renal tubular cell handling of digoxin and ouabain--in vitro study using LLC-PK1 cell lines. (1990) (0)
Cultural Heritage Protection in Israel-Centralization Vs Decentralization of the Heritage Management (2017) (0)
Development of Therapeutic Agents: The Maternal–Fetal Perspective (2011) (0)
Born-Steiner Irritability Scale: Self-Rating (2020) (0)
Piracetam Study: Poorly Designed and Misinterpreted—Reply (2001) (0)
Intravenous Busulfan: Pharmacokinetic Disposition and Clinical Outcomes in Children Undergoing Hematopoietic Stem Cell Transplant. (2005) (0)
Standardized data gathering by teratogen information services: implications for prospective studies (1993) (0)
SSRIs in early pregnancy were associated with increased risk for septal heart defects but not major congenital malformations overall (2009) (0)
Comprar Cancer In Pregnancy And Lactation. The Motherisk Guide | Gideon Koren | 9781107006133 | Cambridge University Press (2011) (0)
Reply to ‘Indication bias or protopathic bias?’ (2015) (0)
Maternal methylmalonic acid concentration: A sensitive marker for neural tube defects (1997) (0)
Patient Perception of Teratogenic Risk (2008) (0)
Complementary and alternative medicine for children--time to enter the evidence-based era. (2007) (0)
Antihistamines, respiratory depression and the sudden infant death syndrome in young children -- A review and recommendations (1996) (0)
Prenatal Vitamins and Pediatric Ca Risk (2006) (0)
Survey of Canadian hospital-based and private pediatricians on clinical pharmacology. (1986) (0)
52 PHARMACOKINETIC PREDISPOSITION TO ENVIRONMENTAL TOBACCO SMOKE; A RISK FACTOR FOR PEDIATRIC ASTHMA (1995) (0)
Stevens-Johnson Syndrome Associated with Codeine in a Child (2002) (0)
The teratogenicity of the drugs of abuse: a symposium. (1994) (0)
Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children. (1990) (0)
Neurocognitive Development of Children Exposed to Doxylamine–Pyridoxine Combination In Utero for Morning Sickness (2014) (0)
Solvents and color vision (2002) (0)
Contents, Vol. 74, 1985 (1985) (0)
Smoking habits, nicotine use, and congenital malformations. (2006) (0)
Addicted mothers to be criminalized in Tennessee. (2014) (0)
Hair Testing and Maternal Drug Exposure (2005) (0)
COST-EFFECTIVENESS OF PHARMACIST PRESCRIBING AUTHORITY FOR EMERGENCY CONTRACEPTION IN BRITISH COLUMBIA (2010) (0)
Chronic HPA axis response to stress in temporomandibular disorder. (2014) (0)
A NEW METHOD FOR REDUCTION OF PAIN IN REPEATED LUMBAR PUNCTURES AND OTHER PAINFUL PROCEDURES IN CHILDREN WITH ACUTE LEUKEMIA: 23 (1989) (0)
Dilemmas in care of the elderly. (1995) (0)
CPS information lacking. (2010) (0)
753: First-trimester exposure to antiepileptic medications is an independent risk factor for major congenital malformations (2011) (0)
A prospective cohort study of fetal and neonatal outcomes in women taking medicinally Ramulus Cinnamomi during pregnancy (2020) (0)
385 INTERPRETATION OF PUTATIVELY TOXIC DIGOXIN SERUM CONCENTRATIONS IN CHILDREN (1985) (0)
Prolongation in Newborns Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval (2008) (0)
PII‐77 (2006) (0)
Dr. Koren Replies (2002) (0)
WD2 PRE-TERM PREGNANCY TERMINATIONS FOLLOWING EXPOSURE TO ANTIDEPRESSANTS:A META-ANALYSIS (2002) (0)
Ethanol cytoxicity is reversed by epomediol in Hep G2 cells (1993) (0)
Dilemmas in care of the elderly. (1995) (0)
Smoke screen: increase in movie stars' smoking on the big screen and its effect on teen smoking. (2005) (0)
Health-Related Quality of Life of Children Prenatally Exposed to Alcohol: A Pilot Study (2002) (0)
Intrauterine causes of tumors in later life (1996) (0)
Selective Serotonin Reuptake Inhibitors : A Prospective Pregnancy Outcome Following Maternal Use of the New (2001) (0)
[Orthostatic induced ventricular tachycardia in a patient with Romano-Ward syndrome]. (1985) (0)
Prenatal Vitamins and Reducing Pediatric Cancer Risk (2006) (0)
Letter to the Editor: In Response. (2015) (0)
, Julia Klein and Gideon Koren 41 DIAGNOSIS OF FASD IN NEONATAL HAIR Unlike ethanol , FAEE persist in blood (2006) (0)
Prise en charge de l’infection à la varicelle pendant la grossesse (2012) (0)
Neurotropic Drugs in Pregnancy and Lactation from the Point of View of the Clinical Teratologist (2021) (0)
SUBOPTIMAL MANAGEMENT OF PAIN CRISES IN SICKLE CELL DISEASE: PROSPECTIVE OBSERVATIONS (1990) (0)
Substance Use in Pregnancy: Managing the High-Risk Patient. (2017) (0)
Contents, Vol. 36, 1984 (1984) (0)
Book Review: Problems in Pediatric Drug Therapy, 4th Edition (2003) (0)
172: Insulin detemir in pregnancy: does it cross the placenta? (2015) (0)
Ginger for Nausea and Vomiting (2005) (0)
Handbook of Female Psychopharmacology (2003) (0)
Retraction: acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis. (2004) (0)
No Association Between Maternal Post-partum Depression and Vaccination Uptake of Infants: A Matched Cohort Study in a Large Health Maintenance Organization Database in Israel (2022) (0)
The quinidine-digoxin interaction (1982) (0)
Prevalence of heavy fetal alcohol exposure by analysis of meconium fatty acid ethyl esters; A nat ionwide canadian study (2018) (0)
Organic Solvents : A Prospective Controlled Study Pregnancy Outcome Following Gestational Exposure to Correction (1999) (0)
DRINKING AND PREGNANCY. AUTOR'S REPLY (1991) (0)
Assessing analgesia in infants and toddlers (1991) (0)
Fetal Safety of Methylphenidate - A Systematic Review and Meta Analysis. (2020) (0)
REPORTING NEGATIVE STUDIES IN THE MASS MEDIA. AUTHOR'S REPLIES (1992) (0)
Maternal Noncompliance With Antibiotics During Breast-feeding (1993) (0)
Reversible conversion of phenobarb to its prodrug primidone: A novel finding from a case report (2012) (0)
Two of the authors respond (1995) (0)
Depression in pregnancy: time to stop terrifying pregnant women. (2012) (0)
Authors’ reply re: The fetal safety of clomiphene citrate: a population based retrospective cohort study (2017) (0)
Pregvit: an alternate prenatal supplement for women with nausea and vomiting in pregnancy (2004) (0)
Reproductive outcomes after assisted conception (2013) (0)
The Ivey Consortium For Measuring Drugs In Breastmilk: 52 (2005) (0)
[FETAL ALCOHOL SPECTRUM DISORDER (FASD) AND ADOPTIONS FROM THE FORMER SOVIET UNION]. (2018) (0)
Psychotropic Medications During Pregnancy: Risk to the Fetus-Reply (1993) (0)
Relief of MMR vaccination pain using topical 4% amethocaine (2004) (0)
The placental expression of Human Leukocyte Antigen HLA-F and HLA-E in early normal placentation (2013) (0)
Pharmacognosy – the science of natural source medicines (2006) (0)
Single dose and steady state pharmacokinetics of intravenous acyclovir in children undergoing bone marrow and liver transplant. (1995) (0)
Health-Related Quality of Life of Children Prenatally Exposed to Alcohol (2003) (0)
Evaluation of fetal and neonatal outcomes after ingestion of Cnidium root (Cnidium officinale Makino) during pregnancy. (2021) (0)
From type 2 diabetes to antioxidant activity : a systematic review of the safety and efficacy of common and cassia cinnamon bark 1 (2007) (0)
Pregnancy induced pharmacokinetic changes of heparins - A systematic review of the literature (2018) (0)
Prenatal exposure to paracetamol and SSRIs Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study (2017) (0)
Letter totheEditor Effect ofInfusion Rates on Toxicity ofAmphotericin B (1992) (0)
Treating Symptoms of Morning Sickness: The First Dual Release Combination of Doxylamine-Pyridoxine (2018) (0)
Subject Index, Vol. 36, 1984 (1984) (0)
Treating Morning Sickness (2009) (0)
POSSIBLE MECHANISM OF DIGOXIN-ITRACONAZOLE INTERACTION. AUTHORS' REPLY (1997) (0)
CAN A PREGNANT SUBSTANCE-ADDICTED WOMAN BE FORCED TO STOP FETAL DRUG ABUSE? COMPARING CANADIAN LAW AND JEWISH PERSPECTIVE (2007) (0)
The Summer Institutes in Maternal-Fetal Pharmacology: building critical mass in a neglected area. (2007) (0)
Meconium Testing for Prenatal Acetaminophen Exposure and Attention Deficit Hyperactivity Disorder- Considering Confounding by Indication (2020) (0)
Cocaine inhibits hCG production in JEG-3 cells (1996) (0)
Training Clinicians in Developing Countries on Rational Use of Medications in Children and Pregnant Women (2015) (0)
Drug-Induced Nephrotoxicity in Children (2007) (0)
Fetal outcome following carbon monoxide exposure in pregnancy; A prospective multicenter study (1990) (0)
Toxic Effects of Drugs and Chemicals on the Lungs (1997) (0)
The prevalence of prenatal alcohol exposure in neonates suspected of multiple drug exposure (2003) (0)
Lack of cisplatin-ranitidine interactions in children (1998) (0)
Advice from a teratology information service may not be enough to ensure compliance with folic acid supplementation guidelines (1995) (0)
Letters Correspondance Letters Correspondance (2003) (0)
Morphine Poisoning via Breast Milk (2006) (0)
Fetal pharmacotherapy 3: magnesium sulfate. (2013) (0)
O04 Fetal Outcome following Dydrogesterone Exposure in Pregnancy (2019) (0)
Reducing procedural pain (2006) (0)
Interaction of digoxin with verapamil, indomethacin, and other coadministered drugs: a comparative study in rat tissue. (1983) (0)
IS NIFEDIPINE USE DURING LABOUR AND BREAST-FEEDING SAFE FOR THE NEONATE?1471 (1996) (0)
Neurocognitive development of children exposed in utero to cyclosporine after maternal renal transplant (2008) (0)
PIII-77Repetition of deliberate self-poisoning: A longitudinal population-based study (2006) (0)
Motherisk: the process of counselling in reproductive toxicology (1996) (0)
Cocaine Use by Pregnant Women (2007) (0)
Learning in practice Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department (2004) (0)
Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease (2003) (0)
Dilemmas in care of the elderly. (1996) (0)
Infants of Drug-Addicted Mothers (2012) (0)
24 Use of Amethocaine Gel for Reducing MMR Vaccination Pain (2004) (0)
Risks for FAS. (1999) (0)
Continuous intravenous infusion of morphine for the treatment of severe vaso-occlusive painful crises in children with sickle cell anemia (1991) (0)
Validity of AAPCC Data Base (1994) (0)
PHARMACOKINETICS AND RESPIRATORY PHARMACODYNAMICS OF IV SALBUTAMOL IN NEONATES WITH BRONCHOPULMONARY DYSPLASIA (1987) (0)
Misinterpretations of iron binding capacity ibc determination in the presence of deferoxamine dfo (1990) (0)
WITHDRAWN: Poster presentations. (2020) (0)
Comment on antiepileptics and antipsychotics. (2002) (0)
Comprar Medication Safety in Pregnancy and Breastfeeding | Gideon Koren | 9780071448284 | Mcgraw-Hill Education (2007) (0)
Antidepressant Use in Late Pregnancy (2005) (0)
MONITORING GUIDELINES OF AMIFOSTINE IN THE PEDIATRIC POPULATION: RESULTS OF A PHASE I/II TRIAL OF ICE WITH AMIFOSTINE (1999) (0)
Nonsedating antihistamines in pregnancy. (1997) (0)
[Cold injuries. Part III: superficial cold lesions]. (1976) (0)
388 Pharmacogenetics of Tacrolimus in Pediatric Solid Organ Transplant Recipients (2012) (0)
The Ivey Consensus in Molecular and Clinical Toxicology (2003) (0)
Maternal Drug Abuse (2011) (0)
#18 The Approach to Nausea and Vomiting of Pregnancy in the Arab Population Compared to the Jewish Population in Israel (2019) (0)
Discrepancies between ordered and measured doses in critically ill neonates and children (2002) (0)
Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications (2018) (0)
Risk Factors for and Long-Term Outcome of Ifosphamide-Induced Nephrotoxicity in Children † 778 (1998) (0)
[PR-EMPTIVE TREATMENT FOR HYPEREMESIS GRAVIDARUM]. (2018) (0)
clinical challenge ❖ défi clinique MOTHE RISK UPDATE (0)
Contents Journal of Psychosomatic Obstetrics and Gynecology¶Volume 22, Issue 1, March 2001 (2001) (0)
Therapeutic Drug Monitoring at the Crossroads (2010) (0)
Association between maternal weight and depressive symptoms (2011) (0)
O4: Cases of chronic systemic cannabis exposure in young children determined by hair analysis (2014) (0)
Assisted reproductive technology and the risk of pediatric cancer: Response to Reigstad et al. (2020) (0)
Drug Exposure and the Media (2009) (0)
Maternal exposure to particulate matter early in pregnancy and congenital anomalies in offspring: Analysis of concentration-response relationships in a population-based cohort with follow-up throughout childhood. (2023) (0)
The risk of spontaneous abortion was increased with highlevels, but not with moderate levels, of caffeine consumption (2000) (0)
The pathology and therapy of diabetes mellitus—Predictive value of placental perfusion studies of antidiabetic drugs (2011) (0)
SYSTEMATIC REVIEW OF ECONOMIC EVALUATION STUDIES IN OBSTETRICS, GYNAECOLOGY AND REPRODUCTIVE MEDICINE (2010) (0)
Correction: Pediatric Methadone Poisoning (1999) (0)
PLASMA BENZOYL-TYROSYL-PABA TEST IN EVALUATING EXOCRINE PANCREATIC FUNCTION IN CF: A PHARMACOKINETIC APPROACH (1984) (0)
Response to “Intrauterine exposure to thiopurines” (2012) (0)
The Bentiromide Test Using Plasma pAminobenzoic Acid for Diagnosing Pancreatic Insufficiency in (1991) (0)
140 CONFIRMATION OF GESTATIONAL COCAINE EXPOSURE BY NEONATAL HAIR ANALYSIS (1995) (0)
THE ANTIOXIDANT EFFECT: CAN WE MITIGATE FETAL ALCOHOL SPECTRUM DISORDER WITH ANTIOXIDANTS? (2005) (0)
Deviations from Typical Developmental Trajectories Detectable at 9 Months of Age in Low Risk Children Later Diagnosed with Autism Spectrum Disorder (2018) (0)
The use of diazepam during the treatment of acute iron intoxication in rats, in the absence and presence of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (1995) (0)
Hair Testing and Drug Exposure (2006) (0)
Reply (2004) (0)
[Measurement of drugs in neonatal hair--a window to fetal exposure]. (1995) (0)
Hepatocellular carcinoma in pregnancy (2011) (0)
Original article Iphosphamide-induced nephrotoxicity in children (1992) (0)
Regional Prevalence Of Fetal Alcohol Exposure As Determined By Meconium Analysis: 35 (2005) (0)
119: Pregnancy induced pharmacokinetic changes in atazanavir and lopinavir - systematic review and meta analysis (2018) (0)
Risk and protective factors associated with multiproblem behaviours of Ethiopian young adults in Israel. (2021) (0)
98: Escitalopram use in pregnancy: an observational cohort study (2011) (0)
Amethocaine Gel Vs Lidocaine - Prilocaine Cream for Procedural Pain in Children (1999) (0)
Breast cancer during pregnancy. Approach to rational management. (1998) (0)
Relapse of depressive and anxiety symptoms, and quality-of-life in pregnant users and discontinued users of antidepressants: Results from the OTIS Antidepressants Study (2011) (0)
Treatment for psychiatric disorders is a predictor of problem drinking in pregnant women (2003) (0)
Steady State Concentration [ Css ] and Total Clearance Rate of NAC in Adults , Neonates and Children (2007) (0)
Perinatal Outcome Following Gestational Exposure to Antidepressants; Separating the Effect of Depression, Pharmacotherapy and Other Confounders (1999) (0)
Sensitive Subjective and Objective Visual Function Measures in Stargardt Macular Dystrophy (2005) (0)
Response to: “Comment on: Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List” (2019) (0)
When potent teratogens are irreplaceable drugs: Lessons of thalidomide and isotretinoin (1997) (0)
New Asthma Treatment Guidelines (2005) (0)
Slow CYP2D6 metabolizer phenotype associated with death in a toddler receiving a therapeutic dose of dextromethorphan. 313 (1997) (0)
Effects of Organic Solvents on Reproductive Outcome and Offspring Development (2006) (0)
Medications in Pregnancy: Can We Treat the Mother While Protecting the Unborn? (2015) (0)
Clinical studies on iron chelation in patients with thalassemia major. (1990) (0)
Answer Short-term and low-dose fluconazole exposure, such as that indicated in the treatment of vaginal candidiasis, is not expected to increase the overall risk of major congenital malformations. (2015) (0)
SURVEY STUDY OCCUR ON ISOTRETINOIN: RESULTS OF A 333 WHY DO PREGNANCIES CONTINUE TO (2017) (0)
Can folate prevent neural tube defects after conception? (1995) (0)
Comment: Breast-feeding During Maternal Use of Azathioprine (2007) (0)
Cystic fibrosis during pregnancy. (2002) (0)
Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency (2019) (0)
2 Approach to Safe Use of Medications in Pregnancy (2022) (0)
Early intervention of skin toxicities by panitumumab and clinical outcomes in the clinical setting. (2014) (0)
Holding assets in Israel (2008) (0)
Prevalence of Fetal Alcohol Exposure by Analysis of Meconium Fatty Acid Ethyl Esters; A National Canadian Study (2019) (0)
BNF for Children 2006 (2006) (0)
WH4 PROBIOTICS IN PREGNANCY:A SYSTEMATIC REVIEWAND META-ANALYSIS OF THE SAFETY OF LACTOBACILLUS, BIFIDOBACTERIUM AND SACCHAROMYCES (2008) (0)
Pharmacokinetic Analysis ofCloxacillin LossinChildren Undergoing MajorSurgery withMassive Bleeding (1990) (0)
Determinants of women's decision making regarding gestational antidepressant use (2003) (0)
The role of the placenta in the biotransformation of carcinogenic compounds (1996) (0)
Epidemiology of drug use in pregnancy (2021) (0)
Antidepressants and breast-feeding [12] (multiple letters) (1997) (0)
Effect of Circumcision on Pain Response During Venipuncture in Neonates 1151 (1998) (0)
The useofinfantsindrugresearch when thereisno directbenefit to them: asurveyofCanadianhealthcare professionals servingon ethicscommittees (1988) (0)
THE EFFECT OF PHYSICIANS' COMPLIANCE ON RELAPSE RATE IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDREN (1987) (0)
Incidence of penaal alcohol epoe in Pince Edad Iland: a poplaion-baed decipie d (2014) (0)
Transfer of formic acid across the placenta is rapid and is placentotoxic (2011) (0)
The Journal of Rheumatology Drugs During the First Trimester of Pregnancy Major Malformations Following Exposure to Nonsteroidal Antiinflammatory (2012) (0)
Born-Steiner Irritability Scale: Observer Rating (2020) (0)
128: The Burden of Prenatal Exposure to Alcohol: 2013 Revised Measurement of Cost (2014) (0)
Pregnancy outcomes following maternal exposure to second generation antipsychotics: considering polytherapy (2013) (0)
Reporting Negative Studies in the Mass Media-Reply (1992) (0)
Biobanking in Israel 2016–17; expressed perceptions versus real life enrollment (2017) (0)
Enhancing Earlier Diagnosis of Colorectal Cancer by Algorithmic Analysis of Trends in Complete Blood Counts (2018) (0)
CHARACTERISTICS OF DIGOXIN INTERACTION WITH QUINIDINE, VERAPAMIL AND AMIODARONE: IN VIVO AND IN VITRO STUDIES (1984) (0)
Acute Poisoning During Pregnancy: Observations from the Toxicology Investigators Consortium (2015) (0)
Iconography : Managing skin toxicities related to panitumumab (2014) (0)
Pregnancy outcome following maternal varicella infection in the first 20 weeks of gestation: a controlled multicentre study (1994) (0)
Vaiproic acid use in psychiatry : issues in treating women of reproductive age (2005) (0)
Helpless and Omnipotent: Incongruencies in Canadian Perceptions of ‘Child’ (1993) (0)
Incidence of breastfeeding among women on chronic antithyroid therapy (1995) (0)
386 ENDOGENOUS DIGOXIN LIKE SUBSTANCE(S) (EDLS) IN NEW BORN INFANTS (1985) (0)
Prenatal Opioid Exposure and Motor Cortex Volume. (2021) (0)
Maternal Exposure to Fine and Coarse Particulate Matter and Congenital Malformations in Offspring Among Members of a Primary Health Care Service: A Population-Based Cohort (2020) (0)
Relationship between neurotoxicity and pharmacokinetics of deferoxamine in children with thalassemia major (1989) (0)
Chronic hypertension in pregnancy: Perinatal outcome in women exposed or unexposed to antihypertensive medications (2011) (0)
Maturity ofchildren toconsent tomedical research: thebabysitter test (1993) (0)
Physicians prescribing for nonpatients: An Ontario perspective (1995) (0)
[Importance of early administration of intravenous streptokinase in acute myocardial infarction]. (1986) (0)
Safety assessment in pediatric studies. (2011) (0)
The prevalence of iron deficiency anemia among African asylum seeking children residing in Tel Aviv (2019) (0)
Markers of urine tampering—detection of sample tampering in an opiate dependency program (1997) (0)
Pharmacokinetics of arginine butyrate in patients with hemoglobinopathy. (1996) (0)
Risk of Major Congenital Malformations after First Trimester Exposure to Topical Azoles (2017) (0)
Pregnancy outcome following gestational exposure to echinacea – a prospective controlled study (2010) (0)
PEDIATRICS AND NEONATAL NURSING (2016) (0)
Efficts of Perioperatiae Oral Amantad ; ine on Postoperatiue Pain and Morptltine Consumpti , on in Patients after Rad ; ical Prostatectomy Results of a Preliminary Stud . y (2011) (0)
The effectiveness of deferiprone in thalassemia. (1997) (0)
The maternal drinking history guide: development of a national educational tool. (2013) (0)
Corticosteroid Treatment of Croup-Reply (1984) (0)
VDTs: is there a danger of radiation? (1986) (0)
[Failure of diphenylhydantoin treatment in children]. (1980) (0)
[Overdose of chloral derivatives in children]. (1980) (0)
FAILURE TO ACHIEVE THERAPEUTIC ACETYL SALICYLIC ACID (ASA) CONCENTRATIONS IN CHILDREN WITH KAWASAKI DISEASE (KD) (1984) (0)
Obstetric Anesthesia The Safety of Metoclopramide Use in the First Trimester of Pregnancy (2010) (0)
Aspirin therapy in Kawasaki syndrome. (1985) (0)
[Determination of hemoglobin type in children with infectious nonspecific polyarthritis]. (1967) (0)
Pursuing teratogenic causes of multiple congenital contractures. (1988) (0)
[Medical management of seizures during infancy and childhood]. (1989) (0)
Organic Solvent Exposure During Pregnancy and Congenital Malformations—Reply (1999) (0)
333 WHY DO PREGNANCIES CONTINUE TO OCCUR ON ISOTRETINOIN: RESULTS OF A SURVEY STUDY (2005) (0)
Cardiac Arrest in Pregnancy (2015) (0)
Serologic response to COVID-19 infection or vaccination in pediatric kidney transplant recipients compared to healthy children (2023) (0)
Renal ontogeny of ifosfamide nephrotoxicity (2005) (0)
Pharmacokinetics of high doses of cyanocobalamin administered by i.v. injection in healthy volunteers (2004) (0)
Pregnancy outcome following gestational exposure to Azithromycin: a prospective controlled study (2004) (0)
Is a fetus a non-consenting patient? (2004) (0)
P10: Removal of environmental contamination of polybrominated diphenyl ethers (PBDEs) in human hair – Clinical and research implications (2014) (0)
P10: Removal of environmental contamination of polybrominated diphenyl ethers (PBDEs) in human hair – Clinical and research implications (2014) (0)
Effect of Methotrexate Treatment for Ectopic Pregnancy on Current and Subsequent Pregnancy (2015) (0)
Dilemmas in care of the elderly. (1995) (0)
Comment: Monitoring Pediatric IV Drugs (1985) (0)
Child neurodevelopment following treatment for nausea and vomiting of pregnancy with diclectin: A prospective controlled study (2005) (0)
PIH2 Duloxetine Use in Pregnancy: A Prospective, Comparative Study of Exposed Infants (2012) (0)
Clinical Relevance of TDM of SSRIs (2006) (0)
Herbal Medicies in Pregnancy and Lactation (2013) (0)

This paper list is powered by the following services:

Other Resources About Gideon Koren

What Schools Are Affiliated With Gideon Koren?

Gideon Koren is affiliated with the following schools:

Gideon Koren's Academic­Influence.com Rankings

Why Is Gideon Koren Influential?

Gideon Koren's Published Works

Published Works

Other Resources About Gideon Koren

What Schools Are Affiliated With Gideon Koren?

Gideon Koren's AcademicInfluence.com Rankings